Items where Division or Clinical Unit is:
ICR divisions > Cancer Biology > Targeted Therapy
ICR divisions > Radiotherapy and Imaging > Targeted Therapy
![]() | Up a level |
- All teams (374)
- ICR divisions (374)
- Cancer Biology (374)
- Targeted Therapy (374)
- Radiotherapy and Imaging (374)
- Targeted Therapy (374)
- Cancer Biology (374)
- ICR divisions (374)
A
Miles, E. A., Clark, C. H., Urbano, M. T. G., Bidmead, M., Dearnaley, D. P., Harrington, K. J., A'Hern, R., Nutting, C. M.
(2005)
The impact of introducing intensity modulated radiotherapy into routine clinical practice.
RADIOTHERAPY AND ONCOLOGY, 77 (3).
pp. 241-246.
ISSN 0167-8140
Urbano, T. G., Clark, C. H., Hansen, V. N., Adams, E. J., A'Hern, R., Miles, E. A., McNair, H., Bidmead, M., Warrington, A. P., Dearnaley, D. P., Harrington, K. J., Nutting, C. M.
(2007)
A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
RADIOTHERAPY AND ONCOLOGY, 85 (1).
pp. 36-41.
ISSN 0167-8140
Box, C., Mendiola, M., Gowan, S., Box, G. M., Valenti, M., Brandon, A. D., Al-Lazikani, B., Rogers, S. J., Wilkins, A., Harrington, K. J., Eccles, S. A.
(2013)
A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.
EUROPEAN JOURNAL OF CANCER, 49 (11).
pp. 2512-2521.
ISSN 0959-8049
B
Urbano, T. G., Clark, C. H., Hansen, V. N., Adams, E. J., Miles, E. A., Mc Nair, H., Bidmead, A. M., Warrington, J., Dearnaley, D. P., Harmer, C., Harrington, K. J., Nutting, C. M.
(2007)
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: Acute toxicity results of a phase I study.
RADIOTHERAPY AND ONCOLOGY, 85 (1).
pp. 58-63.
ISSN 0167-8140
Guerrero Urbano, T., Clark, C., Bidmead, M., Dearnaley, D., Harrington, K., Nutting, C.
(2005)
Intensity Modulated Radiotherapy in Cancer of the Larynx.
In:
Image Guided IMRT.
Springer, Berlin, Germany, 335 - 344.
ISBN 978-354020511-1
Humphreys, M., Urbano, M. T. G., Mubata, C., Mites, E., Harrington, K. J., Bidmead, M., Nutting, C. M.
(2005)
Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging.
RADIOTHERAPY AND ONCOLOGY, 77 (1).
pp. 39-44.
ISSN 0167-8140
Clark, C. H., Miles, E. A., Bidmead, A. M., Mubata, C. D., Harrington, K. J., Nutting, C. M.
(2003)
In regard to Lee et al., IJROBP 2002;53 : 630-637.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55 (4).
p. 1150.
ISSN 0360-3016
Clark, C. H., Bidmead, A. M., Mubata, C. D., Harrington, K. J., Nutting, C. M.
(2004)
Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
RADIOTHERAPY AND ONCOLOGY, 70 (2).
pp. 189-198.
ISSN 0167-8140
D
Vidal, L., Pandha, H. S., Yap, T. A., White, C. L., Twigger, K., Vile, R. G., Melcher, A., Coffey, M., Harrington, K. J., DeBono, J. S.
(2008)
A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer.
CLINICAL CANCER RESEARCH, 14 (21).
pp. 7127-7137.
ISSN 1078-0432
Errington, F., Steele, L., Prestwich, R., Harrington, K. J., Pandha, H. S., Vidal, L., de Bono, J., Selby, P., Coffey, M., Vile, R., Melcher, A.
(2008)
Reovirus activates human dendritic cells to promote innate antitumor immunity.
JOURNAL OF IMMUNOLOGY, 180 (9).
pp. 6018-6026.
ISSN 0022-1767
Yap, T. A., Brunetto, A., Pandha, H., Harrington, K., de Bono, J. S.
(2008)
Reovirus therapy in cancer: has the orphan virus found a home?
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (12).
pp. 1925-1935.
ISSN 1354-3784
Comins, C., Heinemann, L., Harrington, K., Melcher, A., De Bono, J., Pandha, H.
(2008)
Reovirus: Viral therapy for cancer 'as nature intended'.
CLINICAL ONCOLOGY, 20 (7).
pp. 548-554.
ISSN 0936-6555
Vidal, L., Yap, T. A., White, C. L., Twigger, K., Hingorani, M., Agrawal, V., Kaye, S. B., Harrington, K. J., de Bono, J. S.
(2006)
Reovirus and other oncolytic viruses for the targeted treatment of cancer.
TARGETED ONCOLOGY, 1 (3).
pp. 130-150.
ISSN 1776-2596
Wedlake, L., McGough, C., Hackett, C., Thomas, K., Blake, P., Harrington, K., Tait, D., Khoo, V., Dearnaley, D., Andreyev, H. J. N.
(2008)
Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 27 (10).
pp. 980-987.
ISSN 0269-2813
Urbano, M. T. G., Henrys, A. J., Adams, E. J., Norman, A. R., Bedford, J. L., Harrington, K. J., Nutting, C. M., Dearnaley, D. P., Tait, D. M.
(2006)
Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 65 (3).
pp. 907-916.
ISSN 0360-3016
Panek, R., Welsh, L., Dunlop, A., Wong, K. H., Riddell, A. M., Koh, D. M., Schmidt, M. A., Doran, S., McQuaid, D., Hopkinson, G., Richardson, C., Nutting, C. M., Bhide, S. A., Harrington, K. J., Robinson, S. P., Newbold, K. L., Leach, M. O.
(2016)
Repeatability and Sensitivity of T-2* Measurements in Patients With Head and Neck Squamous Cell Carcinoma at 3T.
JOURNAL OF MAGNETIC RESONANCE IMAGING, 44 (1).
pp. 72-80.
ISSN 1053-1807
E
Kirby, A. M., A'Hern, R. P., D'Ambrosio, C., Tanay, M., Syrigos, K. N., Rogers, S. J., Box, C., Eccles, S. A., Nutting, C. M., Harrington, K. J.
(2006)
Gefitinib (ZD1839, Iressa(TM)) as palliative treatment in recurrent or metastatic head and neck cancer.
BRITISH JOURNAL OF CANCER, 94 (5).
pp. 631-636.
ISSN 0007-0920
Rogers, S. J., Box, C., Harrington, K. J., Nutting, C., Rhys-Evans, P., Eccles, S. A.
(2005)
The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.
EXPERT OPINION ON THERAPEUTIC TARGETS, 9 (4).
pp. 769-790.
ISSN 1472-8222
G
Touchefeu, Y., Khan, A. A., Borst, G., Zaidi, S. H., McLaughlin, M., Roulstone, V., Mansfield, D., Kyula, J., Pencavel, T., Karapanagiotou, E. M., Clayton, J., Federspiel, M. J., Russell, S. J., Garrett, M., Collins, I., Harrington, K. J.
(2013)
Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition.
RADIOTHERAPY AND ONCOLOGY, 108 (1).
pp. 24-31.
ISSN 0167-8140
Ross, P. J., Teoh, E. M., A'Hern, R. P., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M., Gore, M. E.
(2009)
Epirubicin, Cisplatin and Protracted Venous Infusion 5-Fluorouracil Chemotherapy for Advanced Salivary Adenoid Cystic Carcinoma.
CLINICAL ONCOLOGY, 21 (4).
pp. 311-314.
ISSN 0936-6555
H
Miah, A. B., Gulliford, S. L., Morden, J., Newbold, K. L., Bhide, S. A., Zaidi, S. H., Hall, E., Harrington, K. J., Nutting, C. M.
(2016)
Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
CLINICAL ONCOLOGY, 28 (9).
E69-E76.
ISSN 0936-6555
Harrington, K., Hall, E., Hawkins, M., Henry, A., MacKay, R., Maughan, T., McDonald, A., Nutting, C., Oelfke, U., Sebag-Montefiore, D., Sharma, R. A., van Herk, M., Faivre-Finn, C., Comm, Art-Net Steering
(2017)
Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET).
CLINICAL ONCOLOGY, 29 (11).
pp. 707-710.
ISSN 0936-6555
Dwivedi, R. C., St Rose, S., Chisholm, E. J., Clarke, P. M., Kerawala, C. J., Nutting, C. M., Rhys-Evans, P. H., Kazi, R., Harrington, K. J.
(2016)
Acoustic parameters of speech: Lack of correlation with perceptual and questionnaire-based speech evaluation in patients with oral and oropharyngeal cancer treated with primary surgery.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38 (5).
pp. 670-676.
ISSN 1043-3074
Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., Billingham, L., Brown, S. R., Buckland, S., Bulbeck, H., Chalmers, A. J., Clack, G., Cranston, A. N., Damstrup, L., Ferraldeschi, R., Forster, M. D., Golec, J., Hagan, R. M., Hall, E., Hanauske, A. R., Harrington, K. J., Haswell, T., Hawkins, M. A., Illidge, T., Jones, H., Kennedy, A. S., McDonald, F., Melcher, T., O'Connor, J. P. B., Pollard, J. R., Saunders, M. P., Sebag-Montefiore, D., Smitt, M., Staffurth, J., Stratford, I. J., Wedge, S. R., Worki, Ncri CTRad Acad-Pharma Joint
(2016)
Clinical development of new drug-radiotherapy combinations.
NATURE REVIEWS CLINICAL ONCOLOGY, 13 (10).
pp. 627-642.
ISSN 1759-4774
Andtbacka, R. H. I., Agarwala, S. S., Ollila, D. W., Hallmeyer, S., Milhem, M., Amatruda, T., Nemunaitis, J. J., Harrington, K. J., Chen, L. S., Shilkrut, M., Ross, M., Kaufman, H. L.
(2016)
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38 (12).
pp. 1752-1758.
ISSN 1043-3074
Harrington, K. J., Bourhis, J.
(2016)
Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? Reply.
JOURNAL OF CLINICAL ONCOLOGY, 34 (17).
pp. 2073-2074.
ISSN 0732-183X
Harrington, K. J., Andtbacka, O. H. I., Collichio, F., Downey, G., Chen, L. S., Szabo, Z., Kaufman, H. L.
(2016)
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial.
Oncotargets and Therapy, 9.
pp. 7081-7093.
ISSN 1178-6930
McEntee, G., Kyula, J. N., Mansfield, D., Smith, H., Wilkinson, M., Gregory, C., Roulstone, V., Coffey, M., Harrington, K. J.
(2016)
Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling.
Oncotarget, 7 (30).
pp. 48517-48532.
ISSN 1949-2553
Mehanna, H., Franklin, N., Compton, N., Robinson, M., Powell, N., Biswas-Baldwin, N., Paleri, V., Hartley, A., Fresco, L., Al-Booz, H., Junor, E., El-Hariry, I., Roberts, S., Harrington, K., Ang, K. K., Dunn, J., Woodman, C.
(2016)
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38.
E1863-E1869.
ISSN 1043-3074
Harrington, K.
(2017)
IMMUNOTHERAPY LINKED TO IMPROVED QUALITY OF LIFE OUTCOMES FOR PATIENTS WITH ADVANCED HEAD AND NECK CANCER, STUDY FINDS.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 148 (9).
pp. 632-633.
ISSN 0002-8177
Alharbi, R. A., Pandha, H. S., Simpson, G. R., Pettengell, R., Poterlowicz, K., Thompson, A., Harrington, K., El-Tanani, M., Morgan, R.
(2017)
Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
ONCOTARGET, 8 (52).
pp. 89566-89579.
ISSN 1949-2553
Lee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., Corry, J., Grau, C., Gregoire, V., Harrington, K. J., Hu, C. S., Kwong, D. L., Langendijk, J. A., Le, Q. T., Lee, N. Y., Lin, J. C., Lu, T. X., Mendenhall, W. M., O'Sullivan, B., Ozyar, E., Peters, L. J., Rosenthal, D. I., Soong, Y. L., Tao, Y. G., Yom, S. S., Wee, J. T.
(2018)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
RADIOTHERAPY AND ONCOLOGY, 126 (1).
pp. 25-36.
ISSN 0167-8140
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., Worden, F., Saba, N. F., Docampo, L. C. I., Haddad, R., Rordorf, T., Kiyota, N., Tahara, M., Monga, M., Lynch, M., Geese, W. J., Kopit, J., Shaw, J. W., Gillison, M. L.
(2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
NEW ENGLAND JOURNAL OF MEDICINE, 375 (19).
pp. 1856-1867.
ISSN 0028-4793
Harrington, K. J., Ferris, R. L., Blumenschein, G., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., Vokes, E. E., Worden, F., Saba, N. F., Kiyota, N., Haddad, R., Tahara, M., Grunwald, V., Shaw, J. W., Monga, M., Lynch, M., Taylor, F., DeRosa, M., Morrissey, L., Cocks, K., Gillison, M. L., Guigay, J.
(2017)
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
LANCET ONCOLOGY, 18 (8).
pp. 1104-1115.
ISSN 1470-2045
Ilett, E., Kottke, T., Thompson, J., Rajani, K., Zaidi, S., Evgin, L., Coffey, M., Ralph, C., Diaz, R., Pandha, H., Harrington, K., Selby, P., Bram, R., Melcher, A., Vile, R.
(2017)
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy.
GENE THERAPY, 24 (1).
pp. 21-30.
ISSN 0969-7128
Kottke, T., Evgin, L., Shim, K. G., Rommelfanger, D., Boisgerault, N., Zaidi, S., Diaz, R. M., Thompson, J., Ilett, E., Coffey, M., Selby, P., Pandha, H., Harrington, K., Melcher, A., Vile, R.
(2017)
Subversion of NK-cell and TNF alpha Immune Surveillance Drives Tumor Recurrence.
CANCER IMMUNOLOGY RESEARCH, 5 (11).
pp. 1029-1045.
ISSN 2326-6066
Sacco, J. J., Evans, M., Harrington, K. J., Man, S., Powell, N., Shaw, R. J., Jones, T. M.
(2016)
Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001.
Human Vaccines & Immunotherapeutics, 12 (4).
pp. 1085-1086.
ISSN 2164-5515
Morgan, R., El-Tanani, M., Hunter, K. D., Harrington, K. J., Pandha, H. S.
(2017)
Targeting HOX/PBX dimers in cancer.
Oncotarget, 8 (19).
pp. 32322-32331.
ISSN 1949-2553
Heatley, N., Harrington, K. J., Thway, K.
(2018)
Warthin Tumor-Like Mucoepidermoid Carcinoma.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 26 (1).
pp. 31-33.
ISSN 1066-8969
Relph, K. L., Harrington, K. J., Pandha, H.
(2005)
Adenoviral strategies for the gene therapy of cancer.
SEMINARS IN ONCOLOGY, 32 (6).
pp. 573-582.
ISSN 0093-7754
Seth, R., Khan, A. A., Pencavel, T. D., Wilkinson, M. J., Kyula, J. N., Simpson, G., Pandha, H., Melcher, A., Vile, R., Harris, P. A., Harrington, K. J.
(2015)
Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus-Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma.
PLASTIC AND RECONSTRUCTIVE SURGERY, 135 (2).
pp. 475-487.
ISSN 0032-1052
Syrigos, K. N., Katirtzoglou, N., Kotteas, E., Harrington, K.
(2008)
Adhesion molecules in lung cancer: Implications in the pathogenesis and management.
CURRENT PHARMACEUTICAL DESIGN, 14 (22).
pp. 2173-2183.
ISSN 1381-6128
Burtness, B., Bourhis, J. P., Vermorken, J. B., Harrington, K. J., Cohen, E. E. W.
(2014)
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
TRIALS, 15.
ISSN 1745-6215
Errington, F., Bateman, A., Kottke, T., Thompson, J., Harrington, K., Merrick, A., Hatfield, P., Selby, P., Vile, R., Melcher, A.
(2006)
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
CLINICAL CANCER RESEARCH, 12 (4).
pp. 1333-1341.
ISSN 1078-0432
Kottke, T., Hall, G., Pulido, J., Diaz, R. M., Thompson, J., Chong, H., Selby, P., Coffey, M., Pandha, H., Chester, J., Melcher, A., Harrington, K., Vile, R.
(2010)
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.
JOURNAL OF CLINICAL INVESTIGATION, 120 (5).
pp. 1551-1560.
ISSN 0021-9738
Kottke, T., Pulido, J., Thompson, J., Sanchez-Perez, L., Chong, H., Calderwood, S. K., Selby, P., Harrington, K., Strome, S. E., Melcher, A., Vile, R. G.
(2009)
Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas.
CANCER RESEARCH, 69 (19).
pp. 7767-7774.
ISSN 0008-5472
Merron, A., Baril, P., Martin-Duque, P., de la Vieja, A., Tran, L., Briat, A., Harrington, K. J., McNeish, I. A., Vassaux, G.
(2010)
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 37 (7).
pp. 1377-1385.
ISSN 1619-7070
Chaudhry, S. I., Hooper, S., Nye, E., Williamson, P., Harrington, K., Sahai, E.
(2013)
Autocrine IL-1 beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine INF alpha, signalling to carcinoma-associated fibroblasts.
ONCOGENE, 32 (6).
pp. 747-758.
ISSN 0950-9232
Syrigos, K. N., Karapanagiotou, E., Boura, P., Manegold, C., Harrington, K.
(2011)
Bevacizumab-Induced Hypertension Pathogenesis and Management.
BIODRUGS, 25 (3).
pp. 159-169.
ISSN 1173-8804
Syrigos, K. N., Vile, R. G., Peters, A. M., Harrington, K. J.
(2003)
Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes after intraperitoneal injection.
ACTA ONCOLOGICA, 42 (2).
pp. 147-153.
ISSN 0284-186X
Hingorani, M., Spitzweg, C., Vassaux, G., Newbold, K., Melcher, A., Pandha, H., Vile, R., Harrington, K.
(2010)
The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery.
CURRENT CANCER DRUG TARGETS, 10 (2).
pp. 242-267.
ISSN 1568-0096
Roulstone, V., Pedersen, M., Kyula, J., Mansfield, D., Khan, A. A., McEntee, G., Wilkinson, M., Karapanagiotou, E., Coffey, M., Marais, R., Jebar, A., Errington-Mais, F., Melcher, A., Vile, R., Pandha, H., McLaughlin, M., Harrington, K. J.
(2015)
BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress.
MOLECULAR THERAPY, 23 (5).
pp. 931-942.
ISSN 1525-0016
Dunlop, A., Welsh, L., McQuaid, D., Dean, J., Gulliford, S., Hansen, V., Bhide, S., Nutting, C., Harrington, K., Newbold, K.
(2015)
Brain-Sparing Methods for IMRT of Head and Neck Cancer.
PLOS ONE, 10 (3).
ISSN 1932-6203
Kottke, T., Errington, F., Pulido, J., Galivo, F., Thompson, J., Wongthida, P., Diaz, R. M., Chong, H., Ilett, E., Chester, J., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R.
(2011)
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.
NATURE MEDICINE, 17 (7).
854-U223.
ISSN 1078-8956
Charpidou, A., Gkiozos, I., Konstantinou, M., Eleftheraki, A., Demertzis, P., Harrington, K., Polyzos, A., Syrigos, K. N.
(2011)
Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients.
CANCER LETTERS, 304 (2).
pp. 144-153.
ISSN 0304-3835
Harrington, K. J., Bateman, A. R., Melcher, A. A., Ahmed, A., Vile, R. G.
(2002)
Cancer gene therapy: Part 1. Vector development and regulation of gene expression.
CLINICAL ONCOLOGY, 14 (1).
pp. 3-16.
ISSN 0936-6555
Harrington, K. J., Melcher, A. A., Bateman, A. R., Ahmed, A., Vile, R. G.
(2002)
Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.
CLINICAL ONCOLOGY, 14 (2).
pp. 148-169.
ISSN 0936-6555
Prestwich, R. J., Errington, F., Diaz, R. M., Pandha, H. S., Harrington, K. J., Melcher, A. A., Vile, R. G.
(2009)
The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon.
HUMAN GENE THERAPY, 20 (10).
pp. 1119-1132.
ISSN 1043-0342
Adair, R. A., Roulstone, V., Scott, K. J., Morgan, R., Nuovo, G. J., Fuller, M., Beirne, D., West, E. J., Jennings, V. A., Rose, A., Kyula, J., Fraser, S., Dave, R., Anthoney, D. A., Merrick, A., Prestwich, R., Aldouri, A., Donnelly, O., Pandha, H., Coffey, M., Selby, P., Vile, R., Toogood, G., Harrington, K., Melcher, A. A.
(2012)
Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients.
Science Translational Medicine, 4 (138).
ISSN 1946-6242
Willmon, C., Harrington, K., Kottke, T., Prestwich, R., Melcher, A., Vile, R.
(2009)
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy.
MOLECULAR THERAPY, 17 (10).
pp. 1667-1676.
ISSN 1525-0016
Harrington, K., Alvarez-Vallina, L., Crittenden, M., Gough, M., Chong, W. H., Diaz, R. M., Vassaux, G., Lemoine, N., Vile, R.
(2002)
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?
HUMAN GENE THERAPY, 13 (11).
pp. 1263-1280.
ISSN 1043-0342
Syrigos, K. N., Harrington, K. J., Karayiannakis, A. J., Baibas, N., Katirtzoglou, N., Roussou, P.
(2004)
Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.
ANTICANCER RESEARCH, 24 (3B).
pp. 2027-2031.
ISSN 0250-7005
Harrington, K. J., Puzanov, I., Hecht, J. R., Hodi, F. S., Szabo, Z., Murugappan, S., Kaufman, H. L.
(2015)
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy.
EXPERT REVIEW OF ANTICANCER THERAPY, 15 (12).
pp. 1389-1403.
ISSN 1473-7140
Syrigos, K. N., Karapanagiotou, E., Harrington, K. J.
(2004)
The clinical significance of molecular markers to bladder cancer.
HYBRIDOMA AND HYBRIDOMICS, 23 (6).
pp. 335-342.
ISSN 1536-8599
Terpos, E., Kiagia, M., Karapanagiotou, E. M., Charpidou, A., Dilana, K. D., Nasothimiou, E., Harrington, K. J., Polyzos, A., Syrigos, K. N.
(2009)
The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications.
ANTICANCER RESEARCH, 29 (5).
pp. 1651-1657.
ISSN 0250-7005
Harrington, K. J., Vile, R. G., Melcher, A., Chester, J., Pandha, H. S.
(2010)
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics.
CYTOKINE & GROWTH FACTOR REVIEWS, 21 (2-3, S).
pp. 91-98.
ISSN 1359-6101
Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K., Leitinger, B., Sahai, E.
(2011)
Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6.
NATURE CELL BIOLOGY, 13 (1).
49-U123.
ISSN 1072-8368
Simpson, G. R., Horvath, A., Annels, N. E., Pencavel, T., Metcalf, S., Seth, R., Peschard, P., Price, T., Coffin, R. S., Mostafid, H., Melcher, A. A., Harrington, K. J., Pandha, H. S.
(2012)
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.
BRITISH JOURNAL OF CANCER, 106 (3).
pp. 496-507.
ISSN 0007-0920
Rajani, K., Parrish, C., Kottke, T., Thompson, J., Zaidi, S., Ilett, L., Shim, K. G., Diaz, R. M., Pandha, H., Harrington, K., Coffey, M., Melcher, A., Vile, R.
(2016)
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses.
MOLECULAR THERAPY, 24 (1).
pp. 166-174.
ISSN 1525-0016
Hingorani, M., White, C. L., Agrawal, V. K., Vidal, L., Melcher, A., Harrington, K. J.
(2007)
Combining radiation and cancer gene therapy: A potential marriage of physical and biological targeting?
CURRENT CANCER DRUG TARGETS, 7 (4).
pp. 389-409.
ISSN 1568-0096
Ahmed, A., Thompson, J., Emiliusen, L., Murphy, S., Beauchamp, R. D., Suzuki, K., Alemany, R., Harrington, K., Vile, R. G.
(2003)
A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.
NATURE BIOTECHNOLOGY, 21 (7).
pp. 771-777.
ISSN 1087-0156
Ilett, E., Kottke, T., Donnelly, O., Thompson, J., Willmon, C., Diaz, R., Zaidi, S., Coffey, M., Selby, P., Harrington, K., Pandha, H., Melcher, A., Vile, R.
(2014)
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus.
MOLECULAR THERAPY, 22 (10).
pp. 1851-1863.
ISSN 1525-0016
Adair, R. A., Scott, K. J., Fraser, S., Errington-Mais, F., Pandha, H., Coffey, M., Selby, P., Cook, G. P., Vile, R., Harrington, K. J., Toogood, G., Melcher, A. A.
(2013)
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells.
INTERNATIONAL JOURNAL OF CANCER, 132 (10).
pp. 2327-2338.
ISSN 0020-7136
Syrigos, K. N., Sitara, D., Georgiou, E., Harrington, K. J.
(2002)
Cytotoxic therapy of gastroenteropancreatic (GEP) tumours.
ANTICANCER RESEARCH, 22 (2B).
pp. 1311-1314.
ISSN 0250-7005
Blanchard, M., Shim, K. G., Grams, M. P., Rajani, K., Diaz, R. M., Furutani, K. M., Thompson, J., Olivier, K. R., Park, S. S., Markovic, S. N., Pandha, H., Melcher, A., Harrington, K., Zaidi, S., Vile, R.
(2015)
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93 (3).
pp. 577-587.
ISSN 0360-3016
Ilett, E. J., Prestwich, R. J., Kottke, T., Errington, F., Thompson, J. M., Harrington, K. J., Pandha, H. S., Coffey, M., Selby, P. J., Vile, R. G., Melcher, A. A.
(2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity.
GENE THERAPY, 16 (5).
pp. 689-699.
ISSN 0969-7128
Melcher, A., Bateman, A., Harrington, K., Ahmed, A., Gough, M., Vile, R.
(2002)
Dendritic cells for the immunotherapy of cancer.
CLINICAL ONCOLOGY, 14 (3).
pp. 185-192.
ISSN 0936-6555
Kottke, T., Boisgerault, N., Diaz, R. M., Donnelly, O., Rommelfanger-Konkol, D., Pulido, J., Thompson, J., Mukhopadhyay, D., Kaspar, R., Coffey, M., Pandha, H., Melcher, A., Harrington, K., Selby, P., Vile, R.
(2013)
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence.
NATURE MEDICINE, 19 (12).
pp. 1625-1631.
ISSN 1078-8956
Mubashar, M., Harrington, K. J., Chaudhary, K. S., El-Nasir, L., Stamp, G. W., Peters, A. M.
(2004)
Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
ACTA ONCOLOGICA, 43 (5).
pp. 443-452.
ISSN 0284-186X
Shears, L., Plowright, L., Harrington, K., Pandha, H. S., Morgan, R.
(2008)
Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P.
JOURNAL OF UROLOGY, 180 (5).
pp. 2196-2201.
ISSN 0022-5347
Heinemann, L., Simpson, G. R., Annels, N. E., Vile, R., Melcher, A., Prestwich, R., Harrington, K. J., Pandha, H. S.
(2010)
The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis.
MOLECULAR THERAPY, 18 (12).
pp. 2085-2093.
ISSN 1525-0016
Hoskin, P. J., Robinson, M., Slevin, N., Morgan, D., Harrington, K., Gaffney, C.
(2009)
Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer.
JOURNAL OF CLINICAL ONCOLOGY, 27 (34).
pp. 5751-5756.
ISSN 0732-183X
Bourke, M. G., Salwa, S., Harrington, K. J., Kucharczyk, M. J., Forde, P. F., de Kruijf, M., Soden, D., Tangney, M., Collins, J. K., O'Sullivan, G. C.
(2011)
The emerging role of viruses in the treatment of solid tumours.
CANCER TREATMENT REVIEWS, 37 (8).
pp. 618-632.
ISSN 0305-7372
Ismail, M., Morgan, R., Harrington, K., Davies, J., Pandha, H.
(2009)
Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model.
CRYOBIOLOGY, 59 (2).
pp. 207-213.
ISSN 0011-2240
Linardakis, E., Bateman, A., Phan, V., Ahmed, A., Gough, M., Olivier, K., Kennedy, R., Errington, F., Harrington, K. J., Melcher, A., Vile, R.
(2002)
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.
CANCER RESEARCH, 62 (19).
pp. 5495-5504.
ISSN 0008-5472
White, C. L., Menghistu, T., Twigger, K. R., Searle, P. F., Bhide, S. A., Vile, R. G., Melcher, A. A., Pandha, H. S., Harrington, K. J.
(2008)
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.
GENE THERAPY, 15 (6).
pp. 424-433.
ISSN 0969-7128
Dwivedi, R. C., St Rose, S., Chisholm, E. J., Bisase, B., Amen, F., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2012)
Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients.
ORAL ONCOLOGY, 48 (6).
pp. 547-553.
ISSN 1368-8375
Harrington, K. J., Melcher, A., Vassaux, G., Pandha, H. S., Vile, R. G.
(2008)
Exploiting synergies between radiation and oncolytic viruses.
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 10 (4).
pp. 362-370.
ISSN 1464-8431
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., Sahai, E.
(2007)
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.
NATURE CELL BIOLOGY, 9 (12).
pp. 1392-1400.
ISSN 1465-7392
Boisgerault, N., Kottke, T., Pulido, J., Thompson, J., Diaz, R. M., Rommelfanger-Konkol, D., Embry, A., Saenz, D., Poeschla, E., Pandha, H., Harrington, K., Melcher, A., Selby, P., Vile, R.
(2013)
Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse.
MOLECULAR THERAPY, 21 (8).
pp. 1507-1516.
ISSN 1525-0016
Errington, F., Jones, J., Merrick, A., Bateman, A., Harrington, K., Gough, M., O'Donnell, D., Selby, P., Vile, R., Melcher, A.
(2006)
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming.
GENE THERAPY, 13 (2).
pp. 138-149.
ISSN 0969-7128
Harrington, K. J., Syrigos, K. N.
(2002)
Gene therapy strategies for lung cancer.
PNEUMON, 15 (1).
pp. 19-37.
ISSN 1105-848X
Good, J. S., Harrington, K. J.
(2013)
The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology.
CLINICAL ONCOLOGY, 25 (10).
pp. 569-577.
ISSN 0936-6555
Donnelly, O., Vile, R., Pandha, H., Harrington, K., Melcher, A.
(2012)
The Hitchhiker's Guide to Virotherapy.
Oncotarget, 3 (8).
pp. 735-736.
ISSN 1949-2553
Morgan, R., Simpson, G., Gray, S., Gillett, C., Tabi, Z., Spicer, J., Harrington, K. J., Pandha, H. S.
(2016)
HOX transcription factors are potential targets and markers in malignant mesothelioma.
BMC CANCER, 16.
p. 11.
ISSN 1471-2407
Plowright, L., Harrington, K. J., Pandha, H. S., Morgan, R.
(2009)
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
BRITISH JOURNAL OF CANCER, 100 (3).
pp. 470-475.
ISSN 0007-0920
Dillon, Magnus T., Harrington, Kevin J.
(2015)
Human Papillomavirus-Negative Pharyngeal Cancer.
JOURNAL OF CLINICAL ONCOLOGY, 33 (29).
pp. 3251-61.
ISSN 0732-183X
Dillon, M. T., Harrington, K. J.
(2015)
Human Papillomavirus-Negative Pharyngeal Cancer.
JOURNAL OF CLINICAL ONCOLOGY, 33 (29).
pp. 3251-3261.
ISSN 0732-183X
Prestwich, R. J., Ilett, E. J., Errington, F., Diaz, R. M., Steele, L. P., Kottke, T., Thompson, J., Galivo, F., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A.
(2009)
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication.
CLINICAL CANCER RESEARCH, 15 (13).
pp. 4374-4381.
ISSN 1078-0432
Ismail, M., Morgan, R., Harrington, K., Davies, J., Pandha, H.
(2010)
Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model.
CRYOBIOLOGY, 61 (3).
pp. 268-274.
ISSN 0011-2240
Merrick, A., Errington, F., Milward, K., O'Donnell, D., Harrington, K., Bateman, A., Pandha, H., Vile, R., Morrison, E., Selby, P., Melcher, A.
(2005)
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming.
BRITISH JOURNAL OF CANCER, 92 (8).
pp. 1450-1458.
ISSN 0007-0920
Prestwich, R. J., Harrington, K. J., Vile, R. G., Melcher, A. A.
(2008)
Immunotherapeutic potential of oncolytic virotherapy.
LANCET ONCOLOGY, 9 (7).
pp. 610-612.
ISSN 1470-2045
Kottke, T., Thompson, J., Diaz, R. M., Pulido, J., Willmon, C., Coffey, M., Selby, P., Melcher, A., Harrington, K., Vile, R. G.
(2009)
Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2.
CLINICAL CANCER RESEARCH, 15 (2).
pp. 561-569.
ISSN 1078-0432
Kottke, T., Sanchez-Perez, L., Diaz, R. M., Thompson, J., Chong, H., Harrington, K., Calderwood, S. K., Pulido, J., Georgopoulos, N., Selby, P., Melcher, A., Vile, R.
(2007)
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.
CANCER RESEARCH, 67 (24).
pp. 11970-11979.
ISSN 0008-5472
Errington, F., White, C. L., Twigger, K. R., Rose, A., Scott, K., Steele, L., Ilett, L. J., Prestwich, R., Pandha, H. S., Coffey, M., Selby, P., Vile, R., Harrington, K. J., Melcher, A. A.
(2008)
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
GENE THERAPY, 15 (18).
pp. 1257-1270.
ISSN 0969-7128
Ismail, M., Bokaee, S., Davies, J., Harrington, K. J., Pandha, H.
(2009)
Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy.
BRITISH JOURNAL OF CANCER, 100 (12).
pp. 1889-1895.
ISSN 0007-0920
Ismail, M., Bokaee, S., Morgan, R., Davies, J., Harrington, K. J., Pandha, H.
(2009)
Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy (vol 100, pg 1889, 2009).
[Correction]
Harrington, K. J., Nutting, C. M.
(2002)
Interactions between ionising radiation and drugs in head and neck cancer - how can we maximize the therapeutic index?
CURRENT OPINION IN INVESTIGATIONAL DRUGS (LONDON, ENGLAND: 2000), 3 (5).
pp. 807-811.
ISSN 1472-4472
Ahmed, A., Jevremovic, D., Suzuki, K., Kottke, T., Thompson, J., Emery, S., Harrington, K., Bateman, A., Vile, R.
(2003)
Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
GENE THERAPY, 10 (19).
pp. 1663-1671.
ISSN 0969-7128
Pencavel, T. D., Wilkinson, M. J., Mansfield, D. C., Khan, A. A., Seth, R., Karapanagiotou, E. M., Roulstone, V., Aguilar, R. J., Chen, N. G., Szalay, A. A., Hayes, A. J., Harrington, K. J.
(2015)
Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
INTERNATIONAL JOURNAL OF CANCER, 136 (4).
pp. 965-976.
ISSN 0020-7136
Perlikos, F., Harrington, K. J., Syrigos, K. N.
(2013)
Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 87 (1).
pp. 1-11.
ISSN 1040-8428
Harrington, K. J.
(2001)
Liposomal cancer chemotherapy: current clinical applications and future prospects.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 10 (6).
pp. 1045-1061.
ISSN 1354-3784
Donnelly, O., Harrington, K., Melcher, A., Pandha, H.
(2013)
Live viruses to treat cancer.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 106 (8).
pp. 310-314.
ISSN 0141-0768
Pencavel, T., Seth, R., Hayes, A., Melcher, A., Pandha, H., Vile, R., Harrington, K. J.
(2010)
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
GENE THERAPY, 17 (8).
pp. 949-960.
ISSN 0969-7128
Jennings, V. A., Ilett, E. J., Scott, K. J., West, E. J., Vile, R., Pandha, H., Harrington, K., Young, A., Hall, G. D., Coffey, M., Selby, P., Errington-Mais, F., Melcher, A. A.
(2014)
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
INTERNATIONAL JOURNAL OF CANCER, 134 (5).
pp. 1091-1101.
ISSN 0020-7136
Donnelly, O. G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V., Scott, K., Peach, H., Phillips, R. M., Bond, J., Pandha, H., Harrington, K., Vile, R., Russell, S., Selby, P., Melcher, A. A.
(2013)
Measles virus causes immunogenic cell death in human melanoma.
GENE THERAPY, 20 (1).
pp. 7-15.
ISSN 0969-7128
Touchefeu, Y., Schick, U., Harrington, K. J.
(2012)
Measles virus: a future therapeutic agent in oncology?
M S-MEDECINE SCIENCES, 28 (4).
pp. 388-394.
ISSN 0767-0974
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., Sahai, E.
(2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.
NATURE CELL BIOLOGY, 15 (6).
637-U441.
ISSN 1465-7392
Harrington, K., Jankowska, P., Hingorani, M.
(2007)
Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer.
CLINICAL ONCOLOGY, 19 (8).
pp. 561-571.
ISSN 0936-6555
Sarris, E. G., Harrington, K. J., Saif, M. W., Syrigos, K. N.
(2014)
Multimodal treatment strategies for elderly patients with head and neck cancer.
CANCER TREATMENT REVIEWS, 40 (3).
pp. 465-475.
ISSN 0305-7372
Zaidi, S., Blanchard, M., Shim, K., Ilett, E., Rajani, K., Parrish, C., Boisgerault, N., Kottke, T., Thompson, J., Celis, E., Pulido, J., Selby, P., Pandha, H., Melcher, A., Harrington, K., Vile, R.
(2015)
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine melanoma Model After Treatment With Immunomodulatory Agents.
MOLECULAR THERAPY, 23 (5).
pp. 845-856.
ISSN 1525-0016
Kazi, R., Singh, A., De Cordova, J., Clarke, P., Harrington, K. J., Rhys-Evans, P.
(2005)
A new self-administered questionnaire to determine patient experience with voice prostheses (Blom-Singer valves).
JOURNAL OF POSTGRADUATE MEDICINE, 51 (4).
pp. 253-258.
ISSN 0022-3859
Kyula, J. N., Roulstone, V., Karapanagiotou, E. M., Melcher, A. A., Harrington, K. J.
(2012)
Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer.
EXPERT OPINION ON BIOLOGICAL THERAPY, 12 (12).
pp. 1669-1678.
ISSN 1471-2598
Mansfield, D., Pencavel, T., Kyula, J. N., Zaidi, S., Roulstone, V., Thway, K., Karapanagiotou, L., Khan, A. A., McLaughlin, M., Touchefeu, Y., Seth, R., Melcher, A. A., Vile, R. G., Pandha, H. S., Harrington, K. J.
(2013)
Oncolytic Vaccinia virus and radiotherapy in head and neck cancer.
ORAL ONCOLOGY, 49 (2).
pp. 108-118.
ISSN 1368-8375
Harrington, K. J.
(2013)
Oncolytic Virotherapy Needs Trials, Not Access Programs.
CLINICAL CANCER RESEARCH, 19 (10).
pp. 2595-2597.
ISSN 1078-0432
Touchefeu, Y., Vassaux, G., Harrington, K. J.
(2011)
Oncolytic viruses in radiation oncology.
RADIOTHERAPY AND ONCOLOGY, 99 (3).
pp. 262-270.
ISSN 0167-8140
Prestwich, R. J., Harrington, K. J., Pandha, H. S., Vile, R. G., Melcher, A. A., Errington, F.
(2008)
Oncolytic viruses: a novel form of immunotherapy.
EXPERT REVIEWS IN ANTICANCER THERAPY, 8 (10).
pp. 1581-1588.
ISSN 1473-7140
Pandha, H., Melcher, A., Harrington, K., Vile, R.
(2009)
Oncolytic Viruses: Time to Compare, Contrast, and Combine?
MOLECULAR THERAPY, 17 (6).
pp. 934-935.
ISSN 1525-0016
Patel, R., Barker, H. E., Kyula, J., McLaughlin, M., Dillon, M. T., Schick, U., Hafsi, H., Thompson, A., Khoo, V., Harrington, K., Zaidi, S.
(2017)
An orally bioavailable Chkl inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
RADIOTHERAPY AND ONCOLOGY, 122 (3).
pp. 470-475.
ISSN 0167-8140
Bhide, S. A., Harrington, K. J., Nutting, C. M.
(2007)
Otological toxicity after postoperative radiotherapy for parotid tumours.
CLINICAL ONCOLOGY, 19 (1).
pp. 77-82.
ISSN 0936-6555
Macpherson, I. R., Hooper, S., Serrels, A., McGarry, L., Ozanne, B. W., Harrington, K., Frame, M. C., Sahai, E., Brunton, V. G.
(2007)
p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism.
ONCOGENE, 26 (36).
pp. 5214-5228.
ISSN 0950-9232
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., Stewart, J. S.
(2001)
Phase I-II study of pegylated liposomal ciplastin (SPI-077) in patients with inoperable head and neck cancer.
ANNALS OF ONCOLOGY, 12 (4).
pp. 493-496.
ISSN 0923-7534
Senzer, N. N., Kaufman, H. L., Amatruda, T., Nemunaitis, M., Reid, T., Daniels, G., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., Goldsweig, H., Marshall, T., Love, C., Coffin, R., Nemunaitis, J. J.
(2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma.
JOURNAL OF CLINICAL ONCOLOGY, 27 (34).
pp. 5763-5771.
ISSN 0732-183X
Galanis, E., Markovic, S. N., Suman, V. J., Nuovo, G. J., Vile, R. G., Kottke, T. J., Nevala, W. K., Thompson, M. A., Lewis, J. E., Rumilla, K. M., Roulstone, V., Harrington, K., Linette, G. P., Maples, W. J., Coffey, M., Zwiebel, J., Kendra, K.
(2012)
Phase II Trial of Intravenous Administration of Reolysin (R) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.
MOLECULAR THERAPY, 20 (10).
pp. 1998-2003.
ISSN 1525-0016
Harrington, K. J., Mubashar, M., Peters, A. M.
(2002)
Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules - lessons from liposomes and monoclonal antibodies.
THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE : OFFICIAL PUBLICATION OF THE ITALIAN ASSOCIATION OF NUCLEAR MEDICINE (AIMN) [AND] THE INTERNATIONAL ASSOCIATION OF RADIOPHARMACOLOGY (IAR), 46 (3).
pp. 171-180.
ISSN 1125-0135
Harrington, K., Temam, S., Mehanna, H., D'Cruz, A., Jain, M., D'Onofrio, I., Manikhas, G., Horvath, Z., Sun, Y., Dietzsch, S., Dubinsky, P., Holeckova, P., El-Hariry, I., Franklin, N., Biswas-Baldwin, N., Legenne, P., Wissel, P., Netherway, T., Farrell, J., Ellis, C., Wang-Silvanto, J., Amonkar, M., Ahmed, N., Santillana, S., Bourhis, J.
(2015)
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
JOURNAL OF CLINICAL ONCOLOGY, 33 (35).
pp. 4202-4209.
ISSN 0732-183X
Harrington, K. J., Michielin, O., Malvehy, J., Gruter, I. P., Grove, L., Frauchiger, A. L., Dummer, R.
(2017)
A practical guide to the handling and administration of talimogene laherparepvec in Europe.
ONCOTARGETS AND THERAPY, 10.
pp. 3867-3880.
ISSN 1178-6930
Kottke, T., Chester, J., Ilett, E., Thompson, J., Diaz, R., Coffey, M., Selby, P., Nuovo, G., Pulido, J., Mukhopadhyay, D., Pandha, H., Harrington, K., Melcher, A., Vile, R.
(2011)
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy.
MOLECULAR THERAPY, 19 (10).
pp. 1802-1812.
ISSN 1525-0016
Harrington, K. J., Nutting, C. M., Archer, D. J.
(2004)
Primary malignant melanoma arising in the dorsum of the tongue.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 42 (1).
pp. 78-79.
ISSN 0266-4356
Steele, L., Errington, F., Prestwich, R., Ilett, E., Harrington, K., Pandha, H., Coffey, M., Selby, P., Vile, R., Melcher, A.
(2011)
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming.
Molecular Cancer, 10.
ISSN 1476-4598
Alonso-Camino, V., Rajani, K., Kottke, T., Rommelfanger-Konkol, D., Zaidi, S., Thompson, J., Pulido, J., Ilett, E., Donnelly, O., Selby, P., Pandha, H., Melcher, A., Harrington, K., Diaz, R. M., Vile, R.
(2014)
The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site.
MOLECULAR THERAPY, 22 (11).
pp. 1936-1948.
ISSN 1525-0016
Syrigos, K. N., Karapanagiotou, E., Harrington, K. J.
(2005)
Prostate cancer in the elderly.
ANTICANCER RESEARCH, 25 (6C).
pp. 4527-4533.
ISSN 0250-7005
Qiao, J., Kottke, T., Willmon, C., Galivo, F., Wongthida, P., Diaz, R. M., Thompson, J., Ryno, P., Barber, G. N., Chester, J., Selby, P., Harrington, K., Melcher, A., Vile, R. G.
(2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy.
NATURE MEDICINE, 14 (1).
pp. 37-44.
ISSN 1078-8956
Kazi, R., Kiverniti, E., De-Cordova, J., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2006)
Quality of life assessment in laryngectomized individuals.
CLINICAL OTOLARYNGOLOGY, 31 (1).
pp. 83-84.
ISSN 0307-7772
Hatfield, P., Merrick, A., Harrington, K., Vile, R., Bateman, A., Selby, P., Melcher, A.
(2005)
Radiation-induced cell death and dendritic cells: Potential for cancer immunotherapy?
CLINICAL ONCOLOGY, 17 (1).
pp. 1-11.
ISSN 0936-6555
Franzese, C., Gujral, D. M., Good, J., Thway, K., Harrington, K. J.
(2013)
Radical Radiotherapy for Radiation-induced Malignancy in the Context of Hereditary Retinoblastoma.
CLINICAL ONCOLOGY, 25 (5).
pp. 330-331.
ISSN 0936-6555
Touchefeu, Y., Franken, P., Harrington, K. J.
(2012)
Radiovirotherapy: Principles and Prospects in Oncology.
CURRENT PHARMACEUTICAL DESIGN, 18 (22).
pp. 3313-3320.
ISSN 1381-6128
Harrington, K., Berrier, A., Robinson, M., Remenar, E., Housset, M., de Mendoza, F. H., Fayette, J., Mehanna, H., El-Hariry, I., Compton, N., Franklin, N., Biswas-Baldwin, N., Lau, M., Legenne, P., Kumar, R.
(2013)
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease.
EUROPEAN JOURNAL OF CANCER, 49 (7).
pp. 1609-1618.
ISSN 0959-8049
Harrington, K. J.
(2010)
Rash conclusions from a phase 3 study of cetuximab?
LANCET ONCOLOGY, 11 (1).
pp. 2-3.
ISSN 1470-2045
Relph, K., Harrington, K., Pandha, H.
(2004)
Recent developments and current status of gene therapy using viral vectors in the United Kingdom.
BRITISH MEDICAL JOURNAL, 329 (7470).
pp. 839-842.
ISSN 0007-1447
Prestwich, R. J., Errington, F., Steele, L. P., Ilett, E. J., Morgan, R. S. M., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A.
(2009)
Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus.
JOURNAL OF IMMUNOLOGY, 183 (7).
pp. 4312-4321.
ISSN 0022-1767
Taylor, G. S., Jia, H., Harrington, K., Lee, L. W., Turner, J., Ladell, K., Price, D. A., Tanday, M., Matthews, J., Roberts, C., Edwards, C., McGuigan, L., Hartley, A., Wilson, S., Hui, E. P., Chan, A. T. C., Rickinson, A. B., Steven, N. M.
(2014)
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer.
CLINICAL CANCER RESEARCH, 20 (19).
pp. 5009-5022.
ISSN 1078-0432
Comins, C., Spicer, J., Protheroe, A., Roulstone, V., Twigger, K., White, C. M., Vile, R., Melcher, A., Coffey, M. C., Mettinger, K. L., Nuovo, G., Cohn, D. E., Phelps, M., Harrington, K. J., Pandha, H. S.
(2010)
REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer.
CLINICAL CANCER RESEARCH, 16 (22).
pp. 5564-5572.
ISSN 1078-0432
Twigger, K., Roulstone, V., Kyula, J., Karapanagiotou, E. M., Syrigos, K. N., Morgan, R., White, C., Bhide, S., Nuovo, G., Coffey, M., Thompson, B., Jebar, A., Errington, F., Melcher, A. A., Vile, R. G., Pandha, H. S., Harrington, K. J.
(2012)
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
BMC CANCER, 12.
ISSN 1471-2407
Touchefeu, Y., Harrington, K. J., Galmiche, J. P., Vassaux, G.
(2010)
Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 32 (8).
pp. 953-968.
ISSN 0269-2813
Dillon, M. T., Good, J. S., Harrington, K. J.
(2014)
Selective Targeting of the G2/M Cell Cycle Checkpoint to Improve the Therapeutic Index of Radiotherapy.
CLINICAL ONCOLOGY, 26 (5).
pp. 257-265.
ISSN 0936-6555
Daniels, G. A., Sanchez-Perez, L., Diaz, R. M., Kottke, T., Thompson, J., Lai, M., Gough, M., Karim, M., Bushell, A., Chong, H., Melcher, A., Harrington, K., Vile, R. G.
(2004)
A simple method to cure established tumors by inflammatory killing of normal cells.
NATURE BIOTECHNOLOGY, 22 (9).
pp. 1125-1132.
ISSN 1087-0156
Merron, A., Peerlinck, I., Martin-Duque, P., Burnet, J., Quintanilla, M., Mather, S., Hingorani, M., Harrington, K., Iggo, R., Vassaux, G.
(2007)
SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.
GENE THERAPY, 14 (24).
pp. 1731-1738.
ISSN 0969-7128
Roulstone, V., Twigger, K., Zaidi, S., Pencavel, T., Kyula, J. N., White, C., McLaughlin, M., Seth, R., Karapanagiotou, E. M., Mansfield, D., Coffey, M., Nuovo, G., Vile, R. G., Pandha, H. S., Melcher, A. A., Harrington, K. J.
(2013)
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.
GENE THERAPY, 20 (5).
pp. 521-528.
ISSN 0969-7128
Kyula, J. N., Khan, A. A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S., Pencavel, T., Touchefeu, Y., Seth, R., Chen, N. G., Yu, Y. A., Zhang, Q., Melcher, A. A., Vile, R. G., Pandha, H. S., Ajaz, M., Szalay, A. A., Harrington, K. J.
(2014)
Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-alpha signaling.
ONCOGENE, 33 (13).
pp. 1700-1712.
ISSN 0950-9232
Pandha, H. S., Heinemann, L., Simpson, G. R., Melcher, A., Prestwich, R., Errington, F., Coffey, M., Harrington, K. J., Morgan, R.
(2009)
Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma.
CLINICAL CANCER RESEARCH, 15 (19).
pp. 6158-6166.
ISSN 1078-0432
Heinemann, L., Simpson, G. R., Boxall, A., Kottke, T., Relph, K. L., Vile, R., Melcher, A., Prestwich, R., Harrington, K. J., Morgan, R., Pandha, H. S.
(2011)
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
BMC CANCER, 11.
ISSN 1471-2407
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., Milhem, M., Cranmer, L., Curti, B., Lewis, K., Ross, M., Guthrie, T., Linette, G. P., Daniels, G. A., Harrington, K., Middleton, M. R., Miller, W. H., Zager, J. S., Ye, Y. N., Yao, B., Li, A., Doleman, S., VanderWalde, A., Gansert, J., Coffin, R. S.
(2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
JOURNAL OF CLINICAL ONCOLOGY, 33 (25).
pp. 2780-2788.
ISSN 0732-183X
Appleton, E. S., Turnbull, S., Ralph, C., West, E., Scott, K., Harrington, K., Pandha, H., Melcher, A.
(2015)
Talimogene laherparepvec in the treatment of melanoma.
EXPERT OPINION ON BIOLOGICAL THERAPY, 15 (10).
pp. 1517-1530.
ISSN 1471-2598
Seth, R., Khan, A. A., Pencavel, T., Harrington, K. J., Harris, P. A.
(2012)
Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction.
LANCET ONCOLOGY, 13 (9).
E392-E402.
ISSN 1470-2045
Peerlinck, I., Merron, A., Baril, P., Conchon, S., Martin-Duque, P., Hindorf, C., Burnet, J., Quintanilla, M., Hingorani, M., Iggo, R., Lemoine, N. R., Harrington, K., Vassaux, G.
(2009)
Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter.
CLINICAL CANCER RESEARCH, 15 (21).
pp. 6595-6601.
ISSN 1078-0432
Harrington, K. J., Syrigos, K. N., Uster, P. S., Zetter, A., Lewanski, C. R., Gullick, W. J., Vile, R. G., Stewart, J. S. W.
(2004)
Targeted radiosensitisation by pegylated liposome-encapsulated 3 ',5 '-O-dipalmitoyl 5-iodo-2 '-deoxyuridine in a head and neck cancer xenograft model.
BRITISH JOURNAL OF CANCER, 91 (2).
pp. 366-373.
ISSN 0007-0920
Morgan, R., Plowright, L., Harrington, K. J., Michael, A., Pandha, H. S.
(2010)
Targeting HOX and PBX transcription factors in ovarian cancer.
BMC CANCER, 10.
ISSN 1471-2407
Morgan, R., Boxall, A., Harrington, K. J., Simpson, G. R., Michael, A., Pandha, H. S.
(2014)
Targeting HOX transcription factors in prostate cancer.
Bmc Urology, 14.
ISSN 1471-2490
Morgan, R., Boxall, A., Harrington, K. J., Simpson, G. R., Gillett, C., Michael, A., Pandha, H. S.
(2012)
Targeting the HOX/PBX dimer in breast cancer.
BREAST CANCER RESEARCH AND TREATMENT, 136 (2).
pp. 389-398.
ISSN 0167-6806
Mubashar, M., Harrington, K. J., Chaudhary, K. S., Lalani, E-N., Stamp, G., Sinnet, D., Glass, D., Peters, A. M.
(2002)
Tc-99m-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
JOURNAL OF NUCLEAR MEDICINE, 43 (4).
pp. 519-525.
ISSN 0161-5505
Harrington, K. J.
(2010)
Topical treatment for oral cancers Winners and losers and oncolytic adenoviruses: who should be down in the mouth?
GENE THERAPY, 17 (12).
pp. 1421-1422.
ISSN 0969-7128
Schick, U., Kyula, J., Barker, H., Patel, R., Zaidi, S., Gregory, C., Hafsi, H., Roulstone, V., Deutsch, E., McLaughlin, M., Harrington, K.
(2015)
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence.
RADIOTHERAPY AND ONCOLOGY, 117 (2).
pp. 364-375.
ISSN 0167-8140
Emiliusen, L., Gough, M., Bateman, A., Ahmed, A., Voellmy, R., Chester, J., Diaz, R. M., Harrington, K., Vile, R.
(2001)
A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
GENE THERAPY, 8 (13).
pp. 987-998.
ISSN 0969-7128
Kottke, T., Galivo, F., Wongthida, P., Diaz, R. M., Thompson, J., Jevremovic, D., Barber, G. N., Hall, G., Chester, J., Selby, P., Harrington, K., Melcher, A., Vile, R. G.
(2008)
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus.
MOLECULAR THERAPY, 16 (7).
pp. 1217-1226.
ISSN 1525-0016
Chester, J., Ruchatz, A., Gough, M., Crittenden, M., Chong, H., Loic-Cosset, L., Diaz, R. M., Harrington, K., Alvarez-Vallina, L., Vile, R.
(2002)
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.
NATURE BIOTECHNOLOGY, 20 (3).
pp. 256-263.
ISSN 1087-0156
Prestwich, R. J., Errington, F., Ilett, E. J., Morgan, R. S. M., Scott, K. J., Kottke, T., Thompson, J., Morrison, E. E., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., Melcher, A. A.
(2008)
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity.
CLINICAL CANCER RESEARCH, 14 (22).
pp. 7358-7366.
ISSN 1078-0432
Barker, H. E., Paget, J. T. E., Khan, A. A., Harrington, K. J.
(2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.
NATURE REVIEWS CANCER, 15 (7).
pp. 409-425.
ISSN 1474-175X
Harrington, K. J., Syrigos, K. N., Vile, R. G.
(2002)
Uposomally targeted cytotoxic drugs for the treatment of cancer.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 54 (12).
pp. 1573-1600.
ISSN 0022-3573
Kottke, T., Diaz, R. M., Kaluza, K., Pulido, J., Galivo, F., Wongthida, P., Thompson, J., Willmon, C., Barber, G. N., Chester, J., Selby, P., Strome, S., Harrington, K., Melcher, A., Vile, R. G.
(2008)
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer.
MOLECULAR THERAPY, 16 (12).
pp. 1910-1918.
ISSN 1525-0016
Richard-Fiardo, P., Franken, P. R., Harrington, K. J., Vassaux, G., Cambien, B.
(2011)
The use of molecular imaging of gene expression by radiotracers in gene therapy.
EXPERT OPINION ON BIOLOGICAL THERAPY, 11 (10).
pp. 1273-1285.
ISSN 1471-2598
Pulido, J., Kottke, T., Thompson, J., Galivo, F., Wongthida, P., Diaz, R. M., Rommelfanger, D., Ilett, E., Pease, L., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R.
(2012)
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.
NATURE BIOTECHNOLOGY, 30 (4).
pp. 336-343.
ISSN 1087-0156
Willmon, C., Diaz, R. M., Wongthida, P., Galivo, F., Kottke, T., Thompson, J., Albelda, S., Harrington, K., Melcher, A., Vile, R.
(2011)
Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide.
MOLECULAR THERAPY, 19 (1).
pp. 140-149.
ISSN 1525-0016
Harrington, K., Vile, R.
(2006)
Virus smuggling, tax evasion and tumor assassination.
NATURE MEDICINE, 12 (5).
pp. 507-509.
ISSN 1078-8956
Kazi, R., Johnson, C., Prasad, V., De Cordova, J., Venkitaraman, R., Nutting, C. M., Clarke, P., Evans, P. R., Harrington, K. J.
(2008)
Quality of life outcome measures following partial glossectomy: Assessment using the UW-QOL scale.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 4 (3).
pp. 116-120.
ISSN 0973-1482
White, C. L., Twigger, K. R., Vidal, L., De Bono, J. S., Coffey, M., Heinemann, L., Morgan, R., Merrick, A., Errington, F., Vile, R. G., Melcher, A. A., Pandha, H. S., Harrington, K. J.
(2008)
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.
GENE THERAPY, 15 (12).
pp. 911-920.
ISSN 0969-7128
Qiao, J., Wang, H. X., Kottke, T., White, C., Twigger, K., Diaz, R. M., Thompson, J., Selby, P., de Bono, J., Melcher, A., Pandha, H., Coffey, M., Vile, R., Harrington, K.
(2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus.
CLINICAL CANCER RESEARCH, 14 (1).
pp. 259-269.
ISSN 1078-0432
Twigger, K., Vidal, L., White, C. L., De Bono, J. S., Bhide, S., Coffey, M., Thompson, B., Vile, R. G., Heinemann, L., Pandha, H. S., Errington, F., Melcher, A. A., Harrington, K. J.
(2008)
Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy.
CLINICAL CANCER RESEARCH, 14 (3).
pp. 912-923.
ISSN 1078-0432
Lolkema, M. P., Arkenau, H. T., Harrington, K., Roxburgh, P., Morrison, R., Roulstone, V., Twigger, K., Coffey, M., Mettinger, K., Gill, G., Evans, T. R. J., de Bono, J. S.
(2011)
A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer.
CLINICAL CANCER RESEARCH, 17 (3).
pp. 581-588.
ISSN 1078-0432
Gami, B., Harrington, K., Blake, P., Dearnaley, D., Tait, D., Davies, J., Norman, A. R., Andreyev, H. J. N.
(2003)
How patients manage gastrointestinal symptoms after pelvic radiotherapy.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 18 (10).
pp. 987-994.
ISSN 0269-2813
Rogers, S. J., Harrington, K. J., Rhys-Evans, P., Charoenrat, P. O., Eccles, S. A.
(2005)
Biological significance of c-erbB family oncogenes in head and neck cancer.
CANCER AND METASTASIS REVIEWS, 24 (1).
pp. 47-69.
ISSN 0167-7659
Rogers, S. J., Harrington, K. J., Eccles, S. A., Nutting, C. M.
(2004)
Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC.
EXPERT REVIEW OF ANTICANCER THERAPY, 4 (4).
pp. 569-583.
ISSN 1473-7140
Luangdilok, S., Box, C., Harrington, K., Rhys-Evans, P., Eccles, S.
(2011)
MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.
EUROPEAN JOURNAL OF CANCER, 47 (4).
pp. 520-529.
ISSN 0959-8049
Luangdilok, S., Box, C., Patterson, L., Court, W., Harrington, K., Pitkin, L., Rhys-Evans, P., O-charoenrat, P., Eccles, S.
(2007)
Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
CANCER RESEARCH, 67 (16).
pp. 7907-7916.
ISSN 0008-5472
Mansfield, D. C., Kyula, J. N., Rosenfelder, N., Chao-Chu, J., Kramer-Marek, G., Khan, A. A., Roulstone, V., McLaughlin, M., Melcher, A. A., Vile, R. G., Pandha, H. S., Khoo, V., Harrington, K. J.
(2016)
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
GENE THERAPY, 23 (4).
pp. 357-368.
ISSN 0969-7128
Khattak, M., Gore, M., Larkin, J., Strauss, D., Thomas, M., Hayes, A., Harrington, K.
(2012)
Adjuvant nodal irradiation in melanoma.
LANCET ONCOLOGY, 13 (8).
E326-E327.
ISSN 1470-2045
Wilkinson, M. J., Smith, H. G., McEntee, G., Kyula-Currie, J., Pencavel, T. D., Mansfield, D. C., Khan, A. A., Roulstone, V., Hayes, A. J., Harrington, K. J.
(2016)
Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis.
Oncotarget, 7 (49).
pp. 81208-81222.
ISSN 1949-2553
McGough, C., Wedlake, L., Baldwin, C., Hackett, C., Norman, A. R., Blake, P., Harrington, K., Tait, D., Khoo, V., Frost, G., Andreyev, H. J. N.
(2008)
Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 27 (11).
pp. 1132-1139.
ISSN 0269-2813
McGough, C., Baldwin, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K., Andreyev, H. J.
(2006)
Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy?
CLINICAL NUTRITION, 25 (1).
pp. 109-116.
ISSN 0261-5614
Khalid, U., McGough, C., Hackett, C., Blake, P., Harrington, K. J., Khoo, V. S., Tait, D., Norman, A. R., Andreyev, H. J. N.
(2006)
A modified Inflammatory Bowel Disease Questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 64 (5).
pp. 1432-1441.
ISSN 0360-3016
Patel, R., Barker, H. E., Kyula, J., McLaughlin, M., Dillon, M. T., Schick, U., Hafsi, H., Thompson, A., Khoo, V., Harrington, K., Zaidi, S.
(2017)
An orally bioavailable Chkl inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
RADIOTHERAPY AND ONCOLOGY, 112 (3).
pp. 470-475.
ISSN 0167-8140
McGough, C., Peacock, N., Hackett, C., Baldwin, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K., Whelan, K., Andreyev, H. J. N.
(2006)
Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: A double-blind controlled study.
CLINICAL NUTRITION, 25 (6).
pp. 906-912.
ISSN 0261-5614
Ahmed, M., Barbachano, Y., Riddell, A., Hickey, J., Newbold, K. L., Viros, A., Harrington, K. J., Marais, R., Nutting, C. M.
(2011)
Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population.
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 165 (2).
pp. 315-322.
ISSN 0804-4643
Mavria, G., Harrington, K. J., Marshall, C. J., Porter, C. D.
(2005)
In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy.
JOURNAL OF GENE MEDICINE, 7 (3).
pp. 263-275.
ISSN 1099-498X
Khan, A. A., Paget, J. T., McLaughlin, M., Kyula, J. N., Wilkinson, M. J., Pencavel, T., Mansfield, D., Roulstone, V., Seth, R., Halle, M., Somaiah, N., Boult, J. K. R., Robinson, S. P., Pandha, H. S., Vile, R. G., Melcher, A. A., Harris, P. A., Harrington, K. J.
(2018)
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.
Science Translational Medicine, 10 (425).
ISSN 1946-6242
Kottke, T., Shim, K. G., Alonso-Camino, V., Zaidi, S., Diaz, R. M., Pulido, J., Thompson, J., Rajani, K. R., Evgin, L., Ilett, E., Pandha, H., Harrington, K., Selby, P., Melcher, A., Vile, R.
(2016)
Immunogenicity of self tumor associated proteins is enhanced through protein truncation.
Molecular Therapy-Oncolytics, 3.
ISSN 2372-7705
Kottke, T., Evgin, L., Shim, K. G., Rommelfanger, D., Boisgerault, N., Zaidi, S., Diaz, R. M., Thompson, J., Ilett, E., Coffey, M., Selby, P., Pandha, H., Harrington, K., Melcher, A., Vile, R.
(2017)
Subversion of NK-cell and TNF alpha Immune Surveillance Drives Tumor Recurrence.
CANCER IMMUNOLOGY RESEARCH, 5 (11).
pp. 1029-1045.
ISSN 2326-6066
Dean, J. A., Welsh, L. C., McQuaid, D., Wong, K. H., Aleksic, A., Dunne, E., Islam, M. R., Patel, A., Patel, P., Petkar, I., Phillips, I., Sham, J., Newbold, K. L., Bhide, S. A., Harrington, K. J., Gulliford, S. L., Nutting, C. M.
(2016)
Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.
RADIOTHERAPY AND ONCOLOGY, 119 (1).
pp. 166-171.
ISSN 0167-8140
Barker, H. E., Patel, R., McLaughlin, M., Schick, U., Zaidi, S., Nutting, C. M., Newbold, K. L., Bhide, S., Harrington, K. J.
(2016)
CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
MOLECULAR CANCER THERAPEUTICS, 15 (9).
pp. 2042-2054.
ISSN 1535-7163
Gujral, D. M., Cheung, W. K., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Hooper, J., Senior, R., Tang, M. X., Harrington, K. J., Nutting, C. M.
(2016)
Contrast enhancement of carotid adventitial vasa vasorum as a biomarker of radiation-induced atherosclerosis.
RADIOTHERAPY AND ONCOLOGY, 120 (1).
pp. 63-68.
ISSN 0167-8140
Bhide, S. A., Thway, K., Lee, J., Wong, K., Clarke, P., Newbold, K. L., Nutting, C. M., Harrington, K. J.
(2016)
Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.
BRITISH JOURNAL OF CANCER, 115 (7).
pp. 825-830.
ISSN 0007-0920
McQuaid, D., Dunlop, A., Nill, S., Franzese, C., Nutting, C. M., Harrington, K. J., Newbold, K. L., Bhide, S. A.
(2016)
Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers.
STRAHLENTHERAPIE UND ONKOLOGIE, 192 (8).
pp. 516-525.
ISSN 0179-7158
Schache, A. G., Powell, N. G., Cuschieri, K. S., Robinson, M., Leary, S., Mehanna, H., Rapozo, D., Long, A., Cubie, H., Junor, E., Monaghan, H., Harrington, K. J., Nutting, C. M., Schick, U., Lau, A. S., Upile, N., Sheard, J., Brougham, K., West, C. M. L., Oguejiofor, K., Thomas, S., Ness, A. R., Pring, M., Thomas, G. J., King, E. V., McCance, D. J., James, J. A., Moran, M., Sloan, P., Shaw, R. J., Evans, M., Jones, T. M.
(2016)
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.
CANCER RESEARCH, 76 (22).
pp. 6598-6606.
ISSN 0008-5472
McLaughlin, M., Barker, H. E., Khan, A. A., Pedersen, M., Dillon, M., Mansfield, D. C., Patel, R., Kyula, J. N., Bhide, S. A., Newbold, K. L., Nutting, C. M., Harrington, K. J.
(2017)
HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.
BMC CANCER, 17.
ISSN 1471-2407
Miah, A. B., Bhide, S. A., Del Rosario, L., Matthews, J., Nicol, R., Tanay, M. A., Gupta, S., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2016)
Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer.
CLINICAL ONCOLOGY, 28 (8).
E61-E67.
ISSN 0936-6555
Dean, J. A., Welsh, L. C., Wong, K. H., Aleksic, A., Dunne, E., Islam, M. R., Patel, A., Patel, P., Petkar, I., Phillips, I., Sham, J., Schick, U., Newbold, K. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Gulliford, S. L.
(2017)
Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
CLINICAL ONCOLOGY, 29 (4).
pp. 263-273.
ISSN 0936-6555
Dean, J. A., Wong, K. H., Welsh, L. C., Jones, A. B., Schick, U., Newbold, K. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Gulliford, S. L.
(2016)
Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
RADIOTHERAPY AND ONCOLOGY, 120 (1).
pp. 21-27.
ISSN 0167-8140
Shah, B. N., Gujral, D. M., Chahal, N. S., Harrington, K. J., Nutting, C. M., Senior, R.
(2016)
Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy A Contrast-Enhanced Ultrasound Study.
Jacc-Cardiovascular Imaging, 9 (6).
pp. 668-675.
ISSN 1936-878X
Dillon, M. T., Barker, H. E., Pedersen, M., Hafsi, H., Bhide, S. A., Newbold, K. L., Nutting, C. M., McLaughlin, M., Harrington, K. J.
(2017)
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei.
MOLECULAR CANCER THERAPEUTICS, 16 (1).
pp. 25-34.
ISSN 1535-7163
Roe, J. W. G., Carding, P. N., Drinnan, M. J., Harrington, K. J., Nutting, C. M.
(2016)
Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38.
E1436-E1444.
ISSN 1043-3074
Richards, T. M., Bhide, S. A., Miah, A. B., Del Rosario, L., Bodla, S., Thway, K., Gujral, D. M., Rooney, K. P., Schick, U., McGovern, T., Grove, L., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2016)
Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
CLINICAL ONCOLOGY, 28 (9).
E77-E84.
ISSN 0936-6555
Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Senior, R., Harrington, K. J., Nutting, C. M.
(2016)
Arterial Stiffness as a Biomarker of Radiation-Induced Carotid Atherosclerosis.
ANGIOLOGY, 67 (3).
pp. 266-271.
ISSN 0003-3197
Roe, J. W. G., Carding, P. N., Rhys-Evans, P. H., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2012)
Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - A web-based survey.
ORAL ONCOLOGY, 48 (4).
pp. 343-348.
ISSN 1368-8375
Cheung, W. K., Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Cosgrove, D. O., Eckersley, R. J., Harrington, K. J., Senior, R., Nutting, C. M., Tang, M. X.
(2015)
ATTENUATION CORRECTION AND NORMALISATION FOR QUANTIFICATION OF CONTRAST ENHANCEMENT IN ULTRASOUND IMAGES OF CAROTID ARTERIES.
ULTRASOUND IN MEDICINE AND BIOLOGY, 41 (7).
pp. 1876-1883.
ISSN 0301-5629
Harrington, K. J., Nutting, C. M.
(2010)
Bravo for PRAVO.
LANCET ONCOLOGY, 11 (5).
pp. 407-408.
ISSN 1470-2045
Kazi, R., Singh, A., Mullan, G. P. J., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2006)
Can objective parameters derived from videofluoroscopic assessment of post-laryngectomy valved speech replace current subjective measures? An e-tool-based analysis.
CLINICAL OTOLARYNGOLOGY, 31 (6).
pp. 518-524.
ISSN 0307-7772
Bhide, S. A., Gulliford, S., Fowler, J., Rosenfelder, N., Newbold, K., Harrington, K. J., Nutting, C. M.
(2010)
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
RADIOTHERAPY AND ONCOLOGY, 97 (1, Sp.).
pp. 86-91.
ISSN 0167-8140
Gujral, D. M., Shah, B. N., Chahal, N. S., Senior, R., Harrington, K. J., Nutting, C. M.
(2014)
Clinical Features of Radiation-induced Carotid Atherosclerosis.
CLINICAL ONCOLOGY, 26 (2).
pp. 94-102.
ISSN 0936-6555
Bhide, S. A., Gulliford, S., Kazi, R., El-Hariry, I., Newbold, K., Harrington, K. J., Nutting, C. M.
(2009)
Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.
RADIOTHERAPY AND ONCOLOGY, 93 (3).
pp. 539-544.
ISSN 0167-8140
Michalaki, V. J., Hall, J., Henk, J. M., Nutting, C. M., Harrington, K. J.
(2003)
Definitive radiotherapy for extramedullary plasmacytomas of the head and neck.
BRITISH JOURNAL OF RADIOLOGY, 76 (910).
pp. 738-741.
ISSN 0007-1285
Dwivedi, R. C., St Rose, S., Chisholm, E. J., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2012)
DEVELOPMENT AND VALIDATION OF FIRST-EVER SPEECH-SPECIFIC PERCEPTUAL SPEECH EVALUATION TOOL FOR PATIENTS WITH HEAD AND NECK CANCER: THE LONDON SPEECH EVALUATION (LSE) SCALE.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 34 (1).
pp. 94-103.
ISSN 1043-3074
Singh, A., Kazi, R., Venkitaraman, R., Kapoor, K., Nutting, C., Clarke, P., Rhys, E. P., Harrington, K.
(2008)
Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report.
CLINICAL OTOLARYNGOLOGY, 33 (1).
pp. 60-63.
ISSN 0307-7772
Bhide, S. A., Gulliford, S., Schick, U., Miah, A., Zaidi, S., Newbold, K., Nutting, C. M., Harrington, K. J.
(2012)
Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
RADIOTHERAPY AND ONCOLOGY, 103 (1).
pp. 88-91.
ISSN 0167-8140
Miah, A. B., Gulliford, S. L., Clark, C. H., Bhide, S. A., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2013)
Dose-response analysis of parotid gland function: What is the best measure of xerostomia?
RADIOTHERAPY AND ONCOLOGY, 106 (3).
pp. 341-345.
ISSN 0167-8140
del Campo, J. M., Hitt, R., Sebastian, P., Carracedo, C., Lokanatha, D., Bourhis, J., Temam, S., Cupissol, D., De Raucourt, D., Maroudias, N., Nutting, C. M., Compton, N., Midwinter, D., Downie, L., Biswas-Baldwin, N., El-Hariry, I., Harrington, K. J.
(2011)
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck.
BRITISH JOURNAL OF CANCER, 105 (5).
pp. 618-627.
ISSN 0007-0920
Kazi, R., Singh, A., Al-Mutairy, A., De Cordova, J., O'Leary, L., Nutting, C., Clarke, P., Evans, P. R., Harrington, K.
(2008)
Electroglottographic analysis of valved speech following total laryngectomy.
LOGOPEDICS PHONIATRICS VOCOLOGY, 33 (1).
pp. 12-21.
ISSN 1401-5439
Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Rhys-Evans, P., Nutting, C. M., Harrington, K. J.
(2008)
Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 70 (2).
pp. 344-352.
ISSN 0360-3016
Wong, K. H., Panek, R., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L.
(2017)
The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.
BRITISH JOURNAL OF RADIOLOGY, 90 (1071).
ISSN 0007-1285
Dwivedi, R. C., St Rose, S., Chisholm, E. J., Georgalas, C., Bisase, B., Amen, F., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2012)
Evaluation of Swallowing by Sydney Swallow Questionnaire (SSQ) in Oral and Oropharyngeal Cancer Patients Treated with Primary Surgery.
Dysphagia, 27 (4).
pp. 491-497.
ISSN 0179-051X
Otter, S., Schick, U., Gulliford, S., Lal, P., Franceschini, D., Newbold, K., Nutting, C., Harrington, K., Bhide, S.
(2015)
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93 (3).
pp. 507-515.
ISSN 0360-3016
Scott-Brown, M., Miah, A., Harrington, K., Nutting, C.
(2010)
Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy.
RADIOTHERAPY AND ONCOLOGY, 97 (2).
pp. 249-257.
ISSN 0167-8140
Dwivedi, R. C., Chisholm, E. J., Khan, A. S., Harris, N. J., Bhide, S. A., St Rose, S., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2012)
An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery.
European Archives of Oto-Rhino-Laryngology, 269 (4).
pp. 1233-1239.
ISSN 0937-4477
Powell, C., Newbold, K., Harrington, K. J., Bhide, S. A., Nutting, C. M.
(2010)
External Beam Radiotherapy for Differentiated Thyroid Cancer.
CLINICAL ONCOLOGY, 22 (6, Sp.).
pp. 456-463.
ISSN 0936-6555
Khan, A., Smellie, J., Nutting, C., Harrington, K., Newbold, K.
(2010)
Familial Nonmedullary Thyroid Cancer: A Review of the Genetics.
THYROID, 20 (7).
pp. 795-801.
ISSN 1050-7256
Dwivedi, R. C., St Rose, S., Roe, J. W., Chisholm, E., Elmiyeh, B., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2010)
First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK.
ISSN 1043-3074
Lee, B., Cook, G., John, L., Harrington, K., Nutting, C.
(2008)
Follicular thyroid carcinoma metastasis to the esophagus detected by (18)FDG PET/CT.
THYROID, 18 (2).
pp. 267-271.
ISSN 1050-7256
Harrington, K. J., Nutting, C. M., Pandha, H. S.
(2005)
Gene therapy for head and neck cancer.
CANCER AND METASTASIS REVIEWS, 24 (1).
pp. 147-164.
ISSN 0167-7659
Harrington, K. J., Billingham, L. J., Brunner, T. B., Burnet, N. G., Chan, C. S., Hoskin, P., Mackay, R. I., Maughan, T. S., Macdougall, J., McKenna, W. G., Nutting, C. M., Oliver, A., Plummer, R., Stratford, I. J., Illidge, T., Radiot, Ncri Clinical Translational
(2011)
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.
BRITISH JOURNAL OF CANCER, 105 (5).
pp. 628-639.
ISSN 0007-0920
Dandekar, P., Harmer, C., Barbachano, Y., Rhys-Evans, P., Harrington, K., Nutting, C., Newbold, K.
(2009)
HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR ANAPLASTIC THYROID CARCINOMA: TOXICITY AND SURVIVAL ANALYSIS.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74 (2).
pp. 518-521.
ISSN 0360-3016
Nutting, C., Harrington, K.
(2004)
In regards to Dr. Glatstein Int J Radiat Oncol Biol Phys 2003;55:561-562, and Dr. Amols, Int J Radiat Oncol Biol Phys 2003;56:1507.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 58 (4).
pp. 1316-1317.
ISSN 0360-3016
Pandha, H., D'Ambrosio, C., Heenan, S., Hyde, N., Di Palma, S., Nutting, C., Relph, K., Harrington, K.
(2009)
Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients.
CLINICAL ONCOLOGY, 21 (4).
pp. 363-364.
ISSN 0936-6555
Bhide, S., Clark, C., Harrington, K., Nutting, C. M.
(2007)
Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
MEDICAL DOSIMETRY, 32 (3).
pp. 188-195.
ISSN 0958-3947
Manikantan, K., Khode, S., Dwivedi, R. C., Palav, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R.
(2009)
Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up.
CANCER TREATMENT REVIEWS, 35 (8).
pp. 744-753.
ISSN 0305-7372
Mendes, R. L., Nutting, C. M., Harrington, K. J.
(2002)
Managing side effects of radiotherapy in head and neck cancer.
HOSPITAL MEDICINE (LONDON, ENGLAND: 1998), 63 (12).
pp. 712-717.
ISSN 1462-3935
Kazi, R., Kiverniti, E., Prasad, V., Venkitaraman, R., Nutting. C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2006)
Multidimensional assessment of female tracheoesophageal prosthetic speech.
CLINICAL OTOLARYNGOLOGY, 31 (6).
pp. 511-517.
ISSN 0307-7772
Lynch, J., Lal, P., Schick, U., Nutting, C. M., Newbold, K., Harrington, K., Bhide, S.
(2014)
Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.
ORAL ONCOLOGY, 50 (9).
pp. 901-906.
ISSN 1368-8375
Welsh, L. C., Dunlop, A. W., McGovern, T., McQuaid, D., Dean, J. A., Gulliford, S. L., Bhide, S. A., Harrington, K. J., Nutting, C. M., Newbold, K. L.
(2014)
Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer.
CLINICAL ONCOLOGY, 26 (12).
pp. 765-775.
ISSN 0936-6555
Dean, J. A., Welsh, L. C., Gulliford, S. L., Harrington, K. J., Nutting, C. M.
(2015)
A novel method for delineation of oral mucosa for radiotherapy dose-response studies.
RADIOTHERAPY AND ONCOLOGY, 115 (1).
pp. 63-66.
ISSN 0167-8140
Harrington, K. J., Kazi, R., Bhide, S. A., Newbold, K., Nutting, C. M.
(2010)
Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents.
INDIAN JOURNAL OF CANCER, 47 (3).
pp. 248-259.
ISSN 0019-509X
Roe, J. W. G., Drinnan, M. J., Carding, P. N., Harrington, K. J., Nutting, C. M.
(2014)
Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
ORAL ONCOLOGY, 50 (12).
pp. 1182-1187.
ISSN 1368-8375
Harrington, K.J., El-Hariry, I.A., Holford, C.S., Lusinchi, A., Nutting, C.M., Rosine, D., Tanay, M., Deutsch, E., Matthews, J., D'Ambrosio, C., Turner, S.J., Pandeshwara, J.S., Bourhis, J.
(2009)
Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
JOURNAL OF CLINICAL ONCOLOGY, 27 (7).
pp. 1100-1107.
ISSN 0732-183X
Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., Medley, L. C., Michael, A., Nutting, C. M., Pandha, H. S., Shorrock, C. A., Simpson, J., Steiner, J., Steven, N. M., Wright, D., Coombes, R. C.
(2006)
A phase I study of OncoVEX(GM-CSF), a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.
CLINICAL CANCER RESEARCH, 12 (22).
pp. 6737-6747.
ISSN 1078-0432
Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., Newbold, K. L., Goldsweig, H., Coffin, R., Nutting, C. M.
(2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck.
CLINICAL CANCER RESEARCH, 16 (15).
pp. 4005-4015.
ISSN 1078-0432
Kazi, R., Kanagalingam, J., Al-Mutairy, A., Nutting, C. M., Clarke, P., Rhys-Evans, P. H., Harrington, K. J.
(2006)
Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer.
CLINICAL OTOLARYNGOLOGY, 31 (1).
p. 83.
ISSN 0307-7772
Newbold, K. L., Bhide, S., Convery, H., Harrington, K. J., Nutting, C. M.
(2012)
Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer.
MEDICAL DOSIMETRY, 37 (3).
pp. 293-295.
ISSN 0958-3947
Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Newbold, K., Rhys-Evans, P., Nutting, C., Harrington, K.
(2008)
Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer.
RADIOTHERAPY AND ONCOLOGY, 87 (2).
pp. 230-236.
ISSN 0167-8140
Sayed, S. I., Elmiyeh, B., Rhys-Evans, P., Syrigos, K. N., Nutting, C. M., Harrington, K. J., Kazi, R.
(2009)
Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions.
CANCER TREATMENT REVIEWS, 35 (5).
pp. 397-402.
ISSN 0305-7372
Kazi, R., De Cordova, J., Kanagalingam, J., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2007)
Quality of life following total laryngectomy: Assessment using the UW-QOL scale.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 69 (2).
pp. 100-106.
ISSN 0301-1569
Kazi, R., Prasad, V., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2006)
Questionnaire analysis of the swallowing-related outcomes following total laryngectomy.
CLINICAL OTOLARYNGOLOGY, 31 (6).
pp. 525-530.
ISSN 0307-7772
Bhide, S. A., Miah, A. B., Harrington, K. J., Newbold, K. L., Nutting, C. M.
(2009)
Radiation-induced Xerostomia: Pathophysiology, Prevention and Treatment.
CLINICAL ONCOLOGY, 21 (10).
pp. 737-744.
ISSN 0936-6555
Maughan, T. S., Illidge, T. M., Hoskin, P., McKenna, W. G., Brunner, T. B., Stratford, I. J., Harrington, K. J., Plummer, R., Billingham, L. J., Nutting, C., Burnet, N. G., Mackay, R. I., Oliver, A., Young, C., Chan, C. S. K., NCRI Clinical Translational Radiot, [Group Author]
(2010)
Radiotherapy Research Priorities for the UK.
CLINICAL ONCOLOGY, 22 (8, Sp.).
pp. 707-709.
ISSN 0936-6555
Wong, K. H., Kuciejewska, A., Sharabiani, M. T. A., Ng-Cheng-Hin, B., Hoy, S., Hurley, T., Rydon, J., Grove, L., Santos, A., Ryugenji, M., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L.
(2017)
A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
RADIOTHERAPY AND ONCOLOGY, 122 (2).
pp. 207-211.
ISSN 0167-8140
Westbury, C. B., Harrington, K. J., Rhys-Evans, P., Archer, D. J., Searle, A. E., Henk, J. M., Black, C. M., Nutting, C. M.
(2003)
Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck.
POSTGRADUATE MEDICAL JOURNAL, 79 (929).
pp. 176-177.
ISSN 0032-5473
Ahmed, M., Hansen, V. N., Harrington, K. J., Nutting, C. M.
(2009)
REDUCING THE RISK OF XEROSTOMIA AND MANDIBULAR OSTEORADIONECROSIS: THE POTENTIAL BENEFITS OF INTENSITY MODULATED RADIOTHERAPY IN ADVANCED ORAL CAVITY CARCINOMA.
MEDICAL DOSIMETRY, 34 (3).
pp. 217-224.
ISSN 0958-3947
Mendes, R. L., Nutting, C. M., Harrington, K. J.
(2004)
Residual or recurrent head and neck cancer presenting with nerve root compression affecting the upper limbs.
BRITISH JOURNAL OF RADIOLOGY, 77 (920).
pp. 688-690.
ISSN 0007-1285
Bhide, S. A., Ahmed, M., Newbold, K., Harrington, K. J., Nutting, C. M.
(2012)
The role of intensity modulated radiotherapy in advanced oral cavity carcinoma.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 8 (6).
pp. 67-71.
ISSN 0973-1482
Bhide, S. A., Kazi, R., Newbold, K., Harrington, K. J., Nutting, C. M.
(2010)
The role of intensity-modulated radiotherapy in head and neck cancer.
INDIAN JOURNAL OF CANCER, 47 (3).
pp. 267-273.
ISSN 0019-509X
Bhide, S. A., Ahmed, M., Barbachano, Y., Newbold, K., Harrington, K. J., Nutting, C. M.
(2008)
Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.
BRITISH JOURNAL OF CANCER, 99 (1).
pp. 57-62.
ISSN 0007-0920
Kazi, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J.
(2009)
Significance and prognostic impact of comorbidity in head and neck cancer.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 5 (3).
pp. 145-147.
ISSN 0973-1482
Roe, J. W. G., Carding, P. N., Dwivedi, R. C., Kazi, R. A., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M.
(2010)
Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - A systematic review.
ORAL ONCOLOGY, 46 (10).
pp. 727-733.
ISSN 1368-8375
Jankowska, P. J., Kong, C., Burke, K., Harrington, K. J., Nutting, C.
(2007)
A systematic study of posterior cervical lymph node irradiation with electrons: Conventional versus customized planning.
RADIOTHERAPY AND ONCOLOGY, 85 (1).
pp. 132-137.
ISSN 0167-8140
Hingorani, M., White, C. L., Zaidi, S., Pandha, H. S., Melcher, A. A., Bhide, S. A., Nutting, C. M., Syrigos, K. N., Vile, R. G., Vassaux, G., Harrington, K. J.
(2010)
Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair.
MOLECULAR THERAPY, 18 (9).
pp. 1599-1605.
ISSN 1525-0016
Sayed, S. I., Manikantan, K., Khode, S., Jagade, M., Kasbekar, V. G., Shah, R., Palav, R. S., Nutting, C. M., Harrington, K. J., Rhys-Evans, P., Kazi, R.
(2010)
Tracheo-oesophageal Party Wall Thickness in Laryngectomised Patients in India: Implications for Surgical Voice Restoration.
JOURNAL OF SURGICAL ONCOLOGY, 101 (1).
pp. 78-83.
ISSN 0022-4790
Nutting, C. M., Bhide, S. A., Harrington, K. J.
(2008)
Treatment of head and neck cancer.
NEW ENGLAND JOURNAL OF MEDICINE, 358 (10).
pp. 1076-1077.
ISSN 0028-4793
Creak, A. L., Harrington, K., Nutting, C.
(2005)
Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy?
CLINICAL ONCOLOGY, 17 (3).
pp. 138-147.
ISSN 0936-6555
Irune, E., Dwivedi, R. C., Nutting, C. M., Harrington, K. J.
(2014)
Treatment-related dysgeusia in head and neck cancer patients.
CANCER TREATMENT REVIEWS, 40 (9).
pp. 1106-1117.
ISSN 0305-7372
Harrington, K. J., Karapanagiotou, E. M., Roulstone, V., Twigger, K. R., White, C. L., Vidal, L., Beirne, D., Prestwich, R., Newbold, K., Ahmed, M., Thway, K., Nutting, C. M., Coffey, M., Harris, D., Vile, R. G., Pandha, H. S., DeBono, J. S., Melcher, A. A.
(2010)
Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers.
CLINICAL CANCER RESEARCH, 16 (11).
pp. 3067-3077.
ISSN 1078-0432
Kazi, R., Singh, A., De Cordova, J., Al-Mutairy, A., Clarke, P., Nutting, C., Rhys-Evans, P., Harrington, K.
(2006)
Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy.
CLINICAL OTOLARYNGOLOGY, 31 (5).
pp. 404-410.
ISSN 0307-7772
Dwivedi, R. C., St Rose, S., Roe, J. W. G., Khan, A. S., Pepper, C., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2010)
Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients.
ORAL ONCOLOGY, 46 (4).
E10-E14.
ISSN 1368-8375
Ahmed, M., Schmidt, M., Sohaib, A., Kong, C., Burke, K., Richardson, C., Usher, M., Brennan, S., Riddell, A., Davies, M., Newbold, K., Harrington, K. J., Nutting, C. M.
(2010)
The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - A study using flexible surface coils.
RADIOTHERAPY AND ONCOLOGY, 94 (2).
pp. 161-167.
ISSN 0167-8140
Kazi, R., De Cordova, J., Singh, A., Venkitaraman, R., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2007)
Voice-related quality of life in laryngectomees: Assessment using the VHI and V-RQOL symptom scales.
JOURNAL OF VOICE, 21 (6).
pp. 728-734.
ISSN 0892-1997
Schick, U., Gujral, D. M., Richards, T. M., Harrington, K. J., Nutting, C. M.
(2012)
Zalutumumab in head and neck cancer.
EXPERT OPINION ON BIOLOGICAL THERAPY, 12 (1).
pp. 119-125.
ISSN 1471-2598
Hall, C. E. J., Harris, R., A'Hern, R., Archer, D. J., Rhys-Evans, P., Henk, J. M., Harrington, K. J., Nutting, C. M.
(2003)
Le Fort I osteotomy and low-dose rate Ir-192 brachytherapy for treatment of recurrent nasopharyngeal tumours.
RADIOTHERAPY AND ONCOLOGY, 66 (1).
pp. 41-48.
ISSN 0167-8140
Harrington, K. J., Michalaki, V. J., Vini, L., Nutting, C. M., Syrigos, K. N., A'Hern, R., Harmer, C. L.
(2005)
Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience.
BRITISH JOURNAL OF RADIOLOGY, 78 (929).
pp. 405-410.
ISSN 0007-1285
Miah, A. B., Schick, U., Bhide, S. A., Guerrero-Urbano, M. T., Clark, C. H., Bidmead, A. M., Bodla, S., Del Rosario, L., Thway, K., Wilson, P., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2015)
A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes.
BRITISH JOURNAL OF CANCER, 112 (1).
pp. 32-38.
ISSN 0007-0920
Clark, C. H., Miles, E. A., Urbano, M. T. G., Bhide, S. A., Bidmead, A. M., Harrington, K. J., Nutting, C. M., UK PARSPORT Trial Management Grp C, [Group Author]
(2009)
Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
BRITISH JOURNAL OF RADIOLOGY, 82 (979).
pp. 585-594.
ISSN 0007-1285
Dwivedi, R. C., Rose, S. S., Chisholm, E. J., Youssefi, P., Hassan, M. S. U., Khan, A. S., Elmiyeh, B., Kerawala, C. J., Clarke, P. M., Nutting, C. M., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2012)
Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study.
European Archives of Oto-Rhino-Laryngology, 269 (2).
pp. 591-599.
ISSN 0937-4477
Hingorani, M., White, C. L., Zaidi, S., Merron, A., Peerlinck, I., Gore, M. E., Nutting, C. M., Pandha, H. S., Melcher, A. A., Vile, R. G., Vassaux, G., Harrington, K. J.
(2008)
Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy.
CLINICAL CANCER RESEARCH, 14 (15).
pp. 4915-4924.
ISSN 1078-0432
Harrington, K., A'Hern, R., Eisen, T., Nutting, C., Gore, M.
(2005)
Patient selection for palliative whole-brain radiotherapy based on RTOG recursive partitioning analysis.
CLINICAL ONCOLOGY, 17 (2).
p. 128.
ISSN 0936-6555
Morris, S. L., Low, S. H., A'Hern, R. P., Eisen, T. G., Gore, M. E., Nutting, C. M., Harrington, K. J.
(2004)
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.
BRITISH JOURNAL OF CANCER, 91 (5).
pp. 829-833.
ISSN 0007-0920
Gujral, D. M., Piercy, D., Morden, J. P., Emson, M., Hall, E., Miah, A. B., Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2014)
Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial.
ORAL ONCOLOGY, 50 (2).
pp. 141-146.
ISSN 1368-8375
Wong, K. H., Panek, R., Welsh, L., McQuaid, D., Dunlop, A., Riddell, A., Murray, I., Du, Y., Chua, S., Koh, D. M., Bhide, S., Nutting, C., Oyen, W. J. G., Harrington, K., Newbold, K. L.
(2016)
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with F-18-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
JOURNAL OF NUCLEAR MEDICINE, 57 (12).
pp. 1843-1850.
ISSN 0161-5505
Newbold, K., Castellano, I., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M., Rhys-Evans, P., Clarke, P., Fisher, C., Harrington, K., Nutting, C.
(2009)
AN EXPLORATORY STUDY INTO THE ROLE OF DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR PERFUSION COMPUTED TOMOGRAPHY FOR DETECTION OF INTRATUMORAL HYPOXIA IN HEAD-AND-NECK CANCER.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74 (1).
pp. 29-37.
ISSN 0360-3016
Borri, M., Schmidt, M. A., Powell, C., Koh, D. M., Riddell, A. M., Partridge, M., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L., Leach, M. O.
(2015)
Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data.
PLOS ONE, 10 (9).
ISSN 1932-6203
Wong, K. H., Panek, R., Dunlop, A., McQuaid, D., Riddell, A., Welsh, L. C., Murray, I., Koh, D. M., Leach, M. O., Bhide, S. A., Nutting, C. M., Oyen, W. J., Harrington, K. J., Newbold, K. L.
(2018)
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45 (5).
pp. 759-767.
ISSN 1619-7070
Newbold, K. L., Partridge, M., Cook, G., Sharma, B., Rhys-Evans, P., Harrington, K. J., Nutting, C. M.
(2008)
Evaluation of the role of (18)FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
ACTA ONCOLOGICA, 47 (7).
pp. 1229-1236.
ISSN 0284-186X
Dandekar, P., Partridge, M., Kazi, R., Nutting, C., Harrington, K., Newbold, K.
(2010)
Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
INDIAN JOURNAL OF CANCER, 47 (3).
pp. 260-266.
ISSN 0019-509X
Agrawal, V. K., Copeland, K. M., Barbachano, Y., Rahim, A., Seth, R., White, C. L., Hingorani, M., Nutting, C. M., Kelly, M., Harris, P., Pandha, H., Melcher, A. A., Vile, R. G., Porter, C., Harrington, K. J.
(2009)
Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery.
GENE THERAPY, 16 (1).
pp. 78-92.
ISSN 0969-7128
Sundar, R., Valeri, N., Harrington, K. J., Yap, T. A.
(2017)
Combining Molecularly Targeted Agents: Is More Always.
CLINICAL CANCER RESEARCH, 23 (5).
pp. 1123-1125.
ISSN 1078-0432
Sourisseau, T., Harrington, K. J., Muller, W. J., Marshall, C. J., White, D. E.
(2011)
Changes in tumor tissue organization in collagen-I sensitize cells to ionizing radiation in an ex vivo model of solid mammary tumor growth and local invasion.
CELL CYCLE, 10 (22).
pp. 3979-3981.
ISSN 1538-4101
Zaidi, S., McLaughlin, M., Bhide, S. A., Eccles, S. A., Workman, P., Nutting, C. M., Huddart, R. A., Harrington, K. J.
(2012)
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage.
PLOS ONE, 7 (4).
ISSN 1932-6203
Zaidi, S. H., Huddart, R. A., Harrington, K. J.
(2009)
Novel targeted radiosensitisers in cancer treatment.
CURRENT DRUG DISCOVERY TECHNOLOGIES, 6 (2).
pp. 103-134.
ISSN 1570-1638
K
Hess, V., A'Hern, R., Nasiri, N., King, D. M., Blake, P. R., Barton, D. P. J., Shepherd, J. H., Ind, T., Bridges, J., Harrington, K., Kaye, S. B., Gore, M. E.
(2004)
Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment.
JOURNAL OF CLINICAL ONCOLOGY, 22 (6).
pp. 1040-1044.
ISSN 0732-183X
Powell, C., Mikropoulos, C., Kaye, S. B., Nutting, C. M., Bhide, S. A., Newbold, K., Harrington, K. J.
(2010)
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers.
CANCER TREATMENT REVIEWS, 36 (7).
pp. 566-575.
ISSN 0305-7372
Henderson, D. R., Murray, J. R., Tree, A. C., Riley, U., Rosenfelder, N. A., Murray, D., Khoo, V. S., van As, N. J.
(2016)
Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate Radiotherapy.
CLINICAL ONCOLOGY, 28 (3).
pp. 226-227.
ISSN 0936-6555
Whitcher, B., Schmid, V. J., Collins, D. J., Orton, M. R., Koh, D. M., de Corcuera, I. D., Parera, M., del Campo, J. M., deSouza, N. M., Leach, M. O., Harrington, K., El-Hariry, I. A.
(2011)
A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 24 (2).
pp. 85-96.
ISSN 0968-5243
Wong, K. H., Panek, R., Dunlop, A., McQuaid, D., Riddell, A., Welsh, L. C., Murray, I., Koh, D. M., Leach, M. O., Bhide, S. A., Nutting, C. M., Oyen, W. J., Harrington, K. J., Newbold, K. L.
(2018)
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45 (5).
pp. 759-767.
ISSN 1619-7070
Panek, R., Welsh, L., Baker, L. C. J., Schmidt, M. A., Wong, K. H., Riddell, A. M., Koh, D. M., Dunlop, A., McQuaid, D., d'Arcy, J. A., Bhide, S. A., Harrington, K. J., Nutting, C. M., Hopkinson, G., Richardson, C., Box, C., Eccles, S. A., Leach, M. O., Robinson, S. P., Newbold, K. L.
(2017)
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.
CLINICAL CANCER RESEARCH, 23 (15).
pp. 4233-4241.
ISSN 1078-0432
L
Wilkins, A., Furness, A., Corbett, R. W., Bloomfield, A., Porta, N., Morris, S., Ali, Z., Larkin, J., Harrington, K.
(2015)
The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma.
BRITISH JOURNAL OF CANCER, 113 (9).
pp. 1275-1281.
ISSN 0007-0920
Welsh, L., Panek, R., McQuaid, D., Dunlop, A., Schmidt, M., Riddell, A., Koh, D. M., Doran, S., Murray, I., Du, Y., Chua, S., Hansen, V., Wong, K. H., Dean, J., Gulliford, S., Bhide, S., Leach, M. O., Nutting, C., Harrington, K., Newbold, K.
(2015)
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.
RADIATION ONCOLOGY, 10.
ISSN 1748-717X
M
Borst, G. R., McLaughlin, M., Kyula, J. N., Neijenhuis, S., Khan, A., Good, J., Zaidi, S., Powell, N. G., Meier, P., Collins, I., Garrett, M. D., Verheij, M., Harrington, K. J.
(2013)
Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85 (4).
pp. 1110-1118.
ISSN 0360-3016
N
Rogers, S. J., Box, C., Nutting, C. M., Harrington, K. J., Eccles, S. A.
(2007)
MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck.
CURRENT ENZYME INHIBITION, 3 (1).
pp. 1-12.
ISSN 1573-4080
Karapanagiotou, E. M., Roulstone, V., Twigger, K., Ball, M., Tanay, M., Nutting, C., Newbold, K., Gore, M. E., Larkin, J., Syrigos, K. N., Coffey, M., Thompson, B., Mettinger, K., Vile, R. G., Pandha, H. S., Hall, G. D., Melcher, A. A., Chester, J., Harrington, K. J.
(2012)
Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies.
CLINICAL CANCER RESEARCH, 18 (7).
pp. 2080-2089.
ISSN 1078-0432
Petkar, I., Bhide, S., Newbold, K., Harrington, K., Nutting, C.
(2017)
Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?
CLINICAL ONCOLOGY, 29 (7).
E110-E118.
ISSN 0936-6555
Dean, J. A., Wong, K. H., Gay, H., Welsh, L. C., Jones, A. B., Schick, U., Oh, J. H., Apte, A., Newbold, K. L., Bhide, S. A., Harrington, K. J., Deasy, J. O., Nutting, C. M., Gulliford, S. L.
(2016)
Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96 (4).
pp. 820-831.
ISSN 0360-3016
Gujral, D. M., Long, M., Roe, J. W. G., Harrington, K. J., Nutting, C. M.
(2017)
Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
CLINICAL ONCOLOGY, 29 (1).
pp. 42-50.
ISSN 0936-6555
Bhide, S. A., Ahmed, M., Rengarajan, V., Powell, C., Miah, A., Newbold, K., Nutting, C. M., Harrington, K. J.
(2009)
ANEMIA DURING SEQUENTIAL INDUCTION CHEMOTHERAPY AND CHEMORADIATION FOR HEAD AND NECK CANCER: THE IMPACT OF BLOOD TRANSFUSION ON TREATMENT OUTCOME.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73 (2).
pp. 391-398.
ISSN 0360-3016
Kazi, R. A., Prasad, V. M. N., Kanagalingam, J., Nutting, C. M., Clarke, P., Rhys-Evans, P., Harrington, K. J.
(2007)
Assessment of the formant frequencies in normal and laryngectomized individuals using linear predictive coding.
JOURNAL OF VOICE, 21 (6).
pp. 661-668.
ISSN 0892-1997
Gujral, D. M., Shah, B. N., Chahal, N. S., Bhattacharyya, S., Hooper, J., Senior, R., Harrington, K. J., Nutting, C. M.
(2016)
Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis.
RADIOTHERAPY AND ONCOLOGY, 118 (2).
pp. 323-329.
ISSN 0167-8140
Manikantan, K., Sayed, S. I., Syrigos, K. N., Rhys-Evans, P., Nutting, C. M., Harrington, K. J., Kazi, R.
(2009)
Challenges for the future modifications of the TNM staging system for head and neck cancer: Case for a new computational model?
CANCER TREATMENT REVIEWS, 35 (7).
pp. 639-644.
ISSN 0305-7372
Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2012)
Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.
BRITISH JOURNAL OF RADIOLOGY, 85 (1013).
pp. 487-494.
ISSN 0007-1285
Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2010)
Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers.
EXPERT REVIEW OF ANTICANCER THERAPY, 10 (3).
pp. 297-300.
ISSN 1473-7140
Dwivedi, R. C., Kazi, R., Agrawal, N., Chisholm, E., Rose, S. S., Elmiyeh, B., Rennie, C., Pepper, C., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Nutting, C. M.
(2010)
Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma.
ORAL ONCOLOGY, 46 (5).
pp. 330-335.
ISSN 1368-8375
Gujral, D. M., Shah, B. N., Bhattacharyya, S., Senior, R., Harrington, K. J., Nutting, C. M.
(2016)
Contrast-enhanced ultrasound to assess plaque neovascularization in irradiated carotid arteries.
International Journal of Cardiology, 202.
pp. 3-4.
ISSN 0167-5273
Manikantan, K., Khode, S., Sayed, S. I., Roe, J., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R.
(2009)
Dysphagia in head and neck cancer.
CANCER TREATMENT REVIEWS, 35 (8).
pp. 724-732.
ISSN 0305-7372
Miah, A. B., Gulliford, S. L., Bhide, S. A., Zaidi, S. H., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2013)
The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT.
RADIOTHERAPY AND ONCOLOGY, 106 (3).
pp. 346-351.
ISSN 0167-8140
Kazi, R., Kanagalingam, J., Venkitaraman, R., Prasad, V., Clarke, P., Nutting, C. M., Rhys-Evans, P., Harrington, K. J.
(2009)
Electroglottographic and Perceptual Evaluation of Tracheoesophageal Speech.
JOURNAL OF VOICE, 23 (2).
pp. 247-254.
ISSN 0892-1997
Wilkins, A. C., Rosenfelder, N., Schick, U., Gupta, S., Thway, K., Nutting, C. M., Harrington, K. J., Newbold, K., Bhide, S. A.
(2013)
Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: A matched-pair analysis.
ORAL ONCOLOGY, 49 (6).
pp. 615-619.
ISSN 1368-8375
Dwivedi, R. C., Kazi, R. A., Agrawal, N., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J.
(2009)
Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers.
CANCER TREATMENT REVIEWS, 35 (5).
pp. 417-424.
ISSN 0305-7372
Powell, C., Schick, U., Morden, J. P., Gulliford, S. L., Miah, A. B., Bhide, S., Newbold, K., Harrington, K. J., Nutting, C. M.
(2014)
Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.
RADIOTHERAPY AND ONCOLOGY, 110 (3).
pp. 416-421.
ISSN 0167-8140
Gujral, D. M., Miah, A. B., Bodla, S., Richards, T. M., Welsh, L., Schick, U., Powell, C. J., Clark, C. H., Bidmead, M. A., Grove, L., Guerrero-Urbano, T., Bhide, S. A., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2014)
Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers.
ORAL ONCOLOGY, 50 (11).
pp. 1089-1097.
ISSN 1368-8375
Dwivedi, R. C., Rose, S. S., Roe, J. W. G., Chisholm, E., Elmiyeh, B., Nutting, C. M., Clarke, P. M., Kerawala, C. J., Rhys-Evans, P. H., Harrington, K. J., Kazi, R.
(2011)
FIRST REPORT ON THE RELIABILITY AND VALIDITY OF SPEECH HANDICAP INDEX IN NATIVE ENGLISH-SPEAKING PATIENTS WITH HEAD AND NECK CANCER.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 33 (3).
pp. 341-348.
ISSN 1043-3074
Syrigos, K. N., Karachalios, D., Karapanagiotou, E. M., Nutting, C. M., Manolopoulos, L., Harrington, K. J.
(2009)
Head and neck cancer in the elderly: An overview on the treatment modalities.
CANCER TREATMENT REVIEWS, 35 (3).
pp. 237-245.
ISSN 0305-7372
Sayed, S. I., Dwivedi, R. C., Katna, R., Garg, A., Pathak, K. A., Nutting, C. M., Rhys-Evans, P., Harrington, K. J., Kazi, R.
(2011)
Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
ORAL ONCOLOGY, 47 (4).
pp. 237-243.
ISSN 1368-8375
Welsh, L., Powell, C., Pratt, B., Harrington, K., Nutting, C., Harmer, C., Newbold, K.
(2013)
Long-Term Outcomes Following Low-Dose Radioiodide Ablation for Differentiated Thyroid Cancer.
Journal of Clinical Endocrinology & Metabolism, 98 (5).
pp. 1819-1825.
ISSN 0021-972X
Nutting, C. M., van Herpen, C. M. L., Miah, A. B., Bhide, S. A., Machiels, J. P., Buter, J., Kelly, C., de Raucourt, D., Harrington, K. J.
(2009)
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma.
ANNALS OF ONCOLOGY, 20 (7).
pp. 1275-1279.
ISSN 0923-7534
Gujral, D. M., Chahal, N., Senior, R., Harrington, K. J., Nutting, C. M.
(2014)
Radiation-induced carotid artery atherosclerosis.
RADIOTHERAPY AND ONCOLOGY, 110 (1).
pp. 31-38.
ISSN 0167-8140
Murray, J. R., Williams, G. R., Harrington, K. J., Newbold, K., Nutting, C. M.
(2012)
Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?
CLINICAL ENDOCRINOLOGY, 77 (1).
ISSN 0300-0664
Kazi, R., Nutting, C. M., Rhys-Evans, P., Harrington, K. J.
(2009)
A Short Perspective on the Surgical Restoration of Alaryngeal Speech.
SOUTHERN MEDICAL JOURNAL, 102 (8).
pp. 838-840.
ISSN 0038-4348
Dwivedi, R. C., Kazi, R., Kanwar, N., Nutting, C. M., Harrington, K. J., Rhys-Evans, P. H.
(2011)
Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?
ANZ JOURNAL OF SURGERY, 81 (9).
pp. 581-583.
ISSN 1445-1433
Bhide, S. A., Davies, M., Burke, K., McNair, H. A., Hansen, V., Barbachano, Y., El-Hariry, I. A., Newbold, K., Harrington, K. J., Nutting, C. M.
(2010)
WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 76 (5).
pp. 1360-1368.
ISSN 0360-3016
Miah, A. B., Bhide, S. A., Guerrero-Urbano, M. T., Clark, C., Bidmead, A. M., St Rose, S., Barbachano, Y., A'Hern, R., Tanay, M., Hickey, J., Nicol, R., Newbold, K. L., Harrington, K. J., Nutting, C. M.
(2012)
DOSE-ESCALATED INTENSITY-MODULATED RADIOTHERAPY IS FEASIBLE AND MAY IMPROVE LOCOREGIONAL CONTROL AND LARYNGEAL PRESERVATION IN LARYNGO-HYPOPHARYNGEAL CANCERS.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82 (2).
pp. 539-547.
ISSN 0360-3016
Welsh, L., Panek, R., Riddell, A., Wong, K., Leach, M. O., Tavassoli, M., Rahman, D., Schmidt, M., Hurley, T., Grove, L., Richards, T., Koh, D. M., Nutting, C., Harrington, K., Newbold, K., Bhide, S.
(2017)
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.
BRITISH JOURNAL OF CANCER, 116 (1).
pp. 28-35.
ISSN 0007-0920
Powell, C., Schmidt, M., Borri, M., Koh, D. M., Partridge, M., Riddell, A., Cook, G., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L.
(2013)
Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer.
RADIOTHERAPY AND ONCOLOGY, 106 (1).
pp. 112-117.
ISSN 0167-8140
Panek, R., Schmidt, M. A., Borri, M., Koh, D. M., Riddell, A., Welsh, L., Dunlop, A., Powell, C., Bhide, S. A., Nutting, C. M., Harrington, K. J., Newbold, K. L., Leach, M. O.
(2016)
Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?
MEDICAL PHYSICS, 43 (11).
pp. 6024-6032.
ISSN 0094-2405
Dunlop, A., McQuaid, D., Nill, S., Murray, J., Poludniowski, G., Hansen, V. N., Bhide, S., Nutting, C., Harrington, K., Newbold, K., Oelfke, U.
(2015)
Comparison of CT number calibration techniques for CBCT-based dose calculation.
STRAHLENTHERAPIE UND ONKOLOGIE, 191 (12).
pp. 970-978.
ISSN 0179-7158
Gurney-Champion, O. J., McQuaid, D., Dunlop, A., Wong, K. H., Welsh, L. C., Riddell, A. M., Koh, D. M., Oelfke, U., Leach, M. O., Nutting, C. M., Bhide, S. A., Harrington, K. J., Panek, R., Newbold, K. L.
(2018)
MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 100 (2).
pp. 306-316.
ISSN 0360-3016
Lee, J. Y., Garcia-Murillas, I., Cutts, R. J., De Castro, D. G., Grove, L., Hurley, T., Wang, F. Q., Nutting, C., Newbold, K., Harrington, K., Turner, N., Bhide, S.
(2017)
Predicting response to radical (chemo) radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma.
BRITISH JOURNAL OF CANCER, 117 (6).
pp. 876-883.
ISSN 0007-0920
Buettner, F., Miah, A. B., Gulliford, S. L., Hall, E., Harrington, K. J., Webb, S., Partridge, M., Nutting, C. M.
(2012)
Novel approaches to improve the therapeutic index of head and neck radiotherapy: An analysis of data from the PARSPORT randomised phase III trial.
RADIOTHERAPY AND ONCOLOGY, 103 (1).
pp. 82-87.
ISSN 0167-8140
P
Newbold, K., Partridge, M., Cook, G., Sohaib, A., Charles-Edwards, E., Rhys-Evans, P., Harrington, K., Nutting, C.
(2006)
Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review.
BRITISH JOURNAL OF RADIOLOGY, 79 (943).
pp. 554-561.
ISSN 0007-1285
W
Nutting, C. M., Normile, P. S., Bedford, J. L., Harrington, K. J., Webb, S.
(2003)
A systematic study of techniques for elective cervical nodal irradiation with anterior or opposed anterior and posterior beams.
RADIOTHERAPY AND ONCOLOGY, 69 (1).
pp. 43-51.
ISSN 0167-8140
Rogers, S. J., Box, C., Chambers, P., Barbachano, Y., Nutting, C. M., Rhys-Evans, P., Workman, P., Harrington, K. J., Eccles, S. A.
(2009)
Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck.
JOURNAL OF PATHOLOGY, 218 (1).
pp. 122-130.
ISSN 0022-3417